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ABSTRACT
Human immunodeficiency virus (HIV) associated neurocognitive disorders
(HAND) affect 50% of individuals with HIV. HAND is characterized by cognitive and
functional impairment and is diagnosed through neuropsychological assessment. The use
of performance validity tests (PVT) is recommended to determine the credibility of
cognitive profiles during neuropsychological testing. However, little is known about the
utility of PVTs within an HIV+ population. The objective of the present study was to
compare the base rate of failure on embedded validity indicators (EVIs) between
individuals diagnosed with HAND, neurocognitively normal individuals with HIV,
undergraduate controls, and undergraduates asked to feign cognitive impairment. The
relationship between EVI failure and neurocognitive performance, as well as selfreported depressive symptoms, was also explored. Cumulative EVI failure produced good
classification accuracy within the student sample, reaffirming their utility in detecting
invalid performance. As predicted, individuals with more severe HAND diagnoses (i.e.,
HIV-associated dementia and mild cognitive impairment) failed more EVIs than
neurocognitively normal individuals. Further, as neurocognitive test performance
decreased, cumulative EVI failures increased. Although directionality of this finding
could not be determined (i.e., do low scores reflect non-credible responding or are EVI
failures false positives in individuals with genuine impairment?), monitoring performance
validity might help explain the well-known fluctuation in cognitive performance over
time in the HAND population. There was no relationship between the number of EVIs
failed and self-reported depressive symptoms or severity, ruling out a commonly
discussed confounding variable in PVT research.
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Chapter I
Introduction
Performance Validity Testing
In neuropsychological assessment, accurate diagnosis and appropriate treatment are
dependent upon the valid presentation of an examinee’s neuropsychological functioning. Often
lacking objective biomarkers, a neuropsychologist’s decisions are based on a combination of
self-reported symptoms, behavioural observations, and performance on objective tests of
cognitive ability (Carone, 2015). However, there is a growing awareness that neuropsychological
test performance is not always an accurate reflection of an examinee’s true ability. Performance
validity tests (PVTs) were developed to assess whether (or the extent to which) the scores on
neuropsychological tests are an accurate reflection of the examinee’s neurocognitive functioning
(Boone, 2013; Larrabee, 2014b).
PVT failures are commonly interpreted as evidence of non-credible responding and alert
the assessor that test results may be invalid and should be interpreted with caution. Non-credible
performance, as indicated by PVT failure, may explain up to 50% of variance on
neuropsychological testing (Green, Rohling, Lees-Haley, & Allen, 2001; Meyers, Volbrecht,
Axelrod, & Reinsch-Boothby, 2011), has produced large effect sizes (d = 1.0), and ultimately
diminished study replicability (Larrabee, 2012).
Brief history. In 1912, Sir John Collie discussed malingering as a significant concern
within medical practice (as referenced in Greher & Wodushek, 2017). This marked the first
recorded instance of validity concerns within a health care setting. By the 1940’s, Andre Rey had
developed the Rey-15 item and dot counting tests. These were the first indicators of performance
validity in neuropsychological testing (Frederick, 2003).
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In the 1990’s, PVT development rapidly increased (Carone, 2015). This growth was a
consequence of the gradual realization that the clinical judgment of psychologists and
psychiatrists about malingering during expert witness testimonies were often unreliable and
inaccurate (Faust, Hart, Guilmette, & Arkes, 1988a, 1988b; Heaton, Smith, Lehman, & Vogt,
1978). In addition, it was during this time period that the first modern book on malingering was
published (Rogers, 1988). Validity testing has since extended beyond neuropsychological
testing. Objective measures of the under- and over-reporting of symptoms have been
incorporated into multiple psychological inventories and structured interviews, such as the L and
K scales in the Minnesota Multiphasic Personality Inventory (Ben-Porath & Tellegen, 2008) as
well as the infrequent and negative impressions subscales of the Personality Assessment
Inventory (Morey, 2007).
Recent literature suggests that the majority of assessors have incorporated measures of
performance validity into their practices (Dandachi-FitzGerald, Merckelbach, & Ponds, 2017;
Jung & Reidenberg, 2007). In 2015, over 92% of 316 neuropsychologists surveyed reported
“often” or “always” using a PVT to detect non-credible performance (Martin, Schroeder, &
Odland, 2015). This is a dramatic increase from a 2007 study reporting only 52% of
neuropsychologists frequently used PVTs (Sharland & Gfeller, 2007). The importance of PVTs
in clinical practice has been highlighted by several professional organizations. The National
Academy of Neuropsychology and the American Academy of Clinical Neuropsychology have
declared that PVTs are “medically necessary” and “important in all evaluations” (Board of
Directors, 2007; Bush et al., 2005).
Invalid performance. Concerns of non-credible presentation vary across clinical
populations and settings. Base rate of failure (BRFail) indicates the proportion of individuals
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within a population who fail a PVT. BRFail on validity tests during neuropsychological exams are
highest for cases involving personal injury, workers compensation, criminal justice, and diseases
lacking clear neuropathological biomarkers (Mittenberg, Patton, Canyock, & Condit, 2002). For
example, chronic pain patients with financial incentive to perform poorly and individuals in
criminal forensic settings have non-credible performance rates as high as 50% (Ardolf, Denney,
& Houston, 2007; Greve, Ord, Bianchini, & Curtis, 2009). In psychoeducational evaluations of
ADHD where external incentives such as medication and academic accommodations are present,
25-50% of examinees are believed to exaggerate their deficits (Marshall et al., 2010; Suhr,
Hammers, Dobbinsbuckland, Zimak, & Hughes, 2008; Sullivan, May, & Galbally, 2007).
Motivation to exaggerate or feign deficits is not the only causal mechanism behind
invalid performance. In settings without identifiable external incentives or in diseases with
objective biomarkers, BRFail are estimated around 10% (Mittenberg et al., 2002). Other
explanations may include emotional distress, somatic concerns, fatigue, pain, sensory
disturbances, and limited English proficiency (Erdodi, Seke, et al., 2017; Erdodi, Nussbaum,
Sagar, Abeare, & Schwartz, 2017; Erdodi et al., 2016; Greher & Wodushek, 2017, Whiteside et
al., 2010). Other psychological diagnoses that can increase the risk of PVT failure include
factitious disorder, oppositional behaviour, and personality disorders (Carone, 2015).
It is worth noting that invalid performance and genuine impairment are not mutually
exclusive. In child custody cases, up to 98.3% of parents pass PVTs (Flaro, Green, & Robertson,
2007). In other words, external incentive to appear cognitively intact on neuropsychological tests
dramatically reduces BRFail. Interestingly, in situations without external incentive to appear
cognitively intact or impaired, BRFail remains relatively high. For example, the cognitive
functioning of undergraduate students is typically higher than average. However, while
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completing neuropsychological tests for research purposes, 37% failed at least 1 PVT (An,
Kaploun, Erdodi, & Abeare, 2017). Thus, it appears that the absence of an apparent external
incentive to perform poorly is not equivalent to the presence of incentives to do well.
Terminology. The language surrounding validity tests has evolved since their initial
conception (Greher & Wodushek, 2017). Originally, PVTs were believed to detect malingering
(Slick, Sherman, & Iverman, 1999). Malingering is the fabrication or intentional exaggeration of
symptoms motivated by secondary external incentives (American Psychiatric Association, 2013).
Based on criteria proposed by Slick et al. (1999), malingering could be identified and further
classified according to the level of confidence associated with the diagnosis (e.g. probable,
possible, or definite). It has since become clear that, although secondary gain and ligation may
motivate an examinee to perform poorly, intent cannot be definitively known. In turn, PVT
failure was gradually re-labeled as “poor effort” (Van Dyke, Millis, Axelrod, & Hanks, 2013).
However, effort remains an ill-defined construct, and carries residual connotations of intent (i.e.,
“not trying hard enough”). Moreover, simulating poor effort produces activation peaks in the
same cortical regions as full effort conditions on the Word Memory Test (Larsen, Allen, Bigler,
Goodrich-Hunsaker, & Hopkins, 2010). Thus, when effort is quantified using a measure of
neural activation, no differences are observed between those intentionally performing poorly and
those trying their best. There may even be a unique pattern of neural activation that occurs while
being deceptive (Kireev, Korotkov, Medvedeva, & Medvedev, 2013), further supporting the idea
that suppressing true ability level while trying to avoid detection likely requires significant
mental energy (i.e., effort). Since many neuropsychological tests begin with statements like “try
your best” or “give your best effort”, failing PVTs can be conceptualized as non-compliance
with instruction (Slick & Sherman, 2013).
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Since 2003, the preferred terminology used to describe PVT failure has been suboptimal,
non-credible, or invalid performance (Boone & Lu, 2003). While still communicating that
neuropsychological test scores may not reflect true cognitive ability, “non-credible” does not
imply etiology (e.g. motivation or volition). Additionally, this language allows the conclusion to
be objective and data-driven, while the clinician remains unbiased (Rickards, Cranston, Touradji,
& Bechtold, 2017).
Free-standing vs. embedded. By design, there are two types of PVTs: free-standing
(stand-alone) and embedded. Free-standing PVTs are independently administered and their
primary purpose is to estimate the credibility of a response set. Although they appear to measure
neurocognitive performance, free-standing PVTs are largely insensitive to brain function and
give little-to-no insight into cognitive ability (Greher & Wodushek, 2017). Commonly used
free-standing PVTs include the Rey-15 item Test (Rey, 1964), Test of Memory Malingering
(TOMM; Tombaugh, 1996), and the Word Choice Test (WCT; Martin et al., 2015; Pearson,
2009). Forced choice recognition is the most commonly utilized paradigm for free-standing
PVTs (Bigler, 2014). In a forced-choice recognition task, an examinee is presented with a set of
stimuli. Later, when target and foil(s) are presented, the examinee is instructed to identify the
previously presented stimulus (Pankratz, 1983). However, one significant limitation of freestanding PVTs is their extension of overall assessment time without contributing any information
regarding the examinee’s current cognitive functioning (Rickards et al., 2017).
Unlike free-standing PVTs, embedded validity indicators (EVIs) are derived from
traditional tests of cognitive ability and therefore, add no extra administration time. As such, they
allow the simultaneous assessment of performance validity and neuropsychological functioning
throughout the testing session. At sufficiently conservative cutoffs, EVIs are insensitive to
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neurological diseases and are indicative of non-credible performance rather than cognitive
deficit. EVIs are difficult to identify as PVTs, making them resistant to coaching and preserving
their psychometric utility (Schutte & Axelrod, 2013). In addition, EVIs are advantageous in that
they directly assess the credibility of a specific response set rather than inferring it through
scores on PVTs administered at different times throughout the assessment (Suhr & Gunstad,
2000).
The mechanisms by which EVIs identify non-credible performance are versatile. The
most common detection method relies on a demonstrated psychometric floor, beyond which a
score is unlikely to occur (Greher & Wodushek, 2017). In other words, EVI failure may be
construed as a deficit so severe that it is rarely observed in clinical populations, raising questions
about its credibility (Babikian, Boone, Lu, & Arnold, 2006). Alternatively, EVIs may identify
errors that are highly unusual even in cases of severe neurological dysfunction. An example of
this is failure to maintain set (FMS) errors within the Wisconsin Card Sorting Task (Greve,
Bianchini, Mathias, Houston, & Crouch, 2002; Lichtenstein, Erdodi, Rai, Mazur-Mosiewicz, &
Flaro, 2016; Suhr & Boyer, 1999). Similarly, another type of EVI looks at atypical patterns
across tests including performing better on more difficult tests compared to easier ones requiring
the same basic skill. For example, an “atypical profile” occurs when an individual performs
significantly better on a WAIS-R Vocabulary subtest compared to the Digit Span subtest
(Mittenberg, Theroux-Fichera, Zielinski, & Heilbronner, 1995) or when a large discrepancy is
observed in the age-corrected scaled score on the Coding and Symbol Search subtests, two
analogous measures of psychomotor processing speed (Erdodi, Abeare, et al., 2017; Glassmire,
Wood, Ta, Kinney, & Nitch, 2018).
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The strength of EVIs is also a source of liability in that they are closely linked to the
cognitive function assessed by the test they are embedded within. Therefore, depending on the
cutoff used, EVIs may be more prone to false-positives than free-standing tests (DeRight &
Carone, 2015). One way to minimize the confound of cognitive ability on PVT outcome is to
consider EVI’s across cognitive domains and/or aggregate multiple EVIs into a single validity
composite (Erdodi, Nussbaum, et al. 2017).
Cutoffs. Cutoff scores separate non-credible performance and genuine dysfunction (Slick
et al., 1999). A score on the passing side of the cutoff represents valid performance whereas a
score on the failing side of the cutoff is interpreted as evidence of invalid performance (Bigler,
2014). PVTs are optimized to minimize the rate of false positives (i.e., maximize specificity) at
the expense of sensitivity. A generally accepted specificity rate is .90, resulting in a less than
10% false positive rate (Larrabee, 2014b).
Cutoff scores are determined a priori, based on previous literature, and allow clinicians
to assess performance validity and estimate the likelihood that the profile is invalid. When
applying cutoffs developed on a given clinical populations to a different diagnostic group it is
important that clinicians reflect on the implications on classification accuracy. For example, an
inflated false positive rate was reported when used on reliable digit span cutoffs in populations
with severe memory disorders, cerebrovascular accidents, and children (Blaskewitz, Merten, &
Kathmann, 2008; Schroeder, Twumasi-Ankrah, Baade, & Marshall, 2012). Certain populations,
such as dementia and intellectual disability, are exempt from PVTs due to the combination of
well-established severe neurological impairment and high BRFail. Given the lack of universally
applicable cutoffs, selecting a cutoff for a population that is yet to be validated carries the risk of
diminished classification accuracy.
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Minimizing false positives. The use and interpretation of cutoff scores varies across
settings, populations, and assessors. However, there is a consensus that PVTs should be
optimized for specificity (i.e., to minimize false positive rates). Larrabee (2014b) identified six
cognitive domains that should be assessed within a comprehensive clinical neuropsychology
battery: (1) verbal symbolic abilities; (2) visuoperceptual and visualspatial judgement and
problem solving; (3) sensorimotor function; (4) attention/working memory; (5) processing speed;
(6) learning and memory-verbal and learning and memory-visual. While most free-standing
PVTs are memory based, EVIs have been developed within each of the six domains. Larrabee
(2014b) recommends completing assessments using neuropsychological batteries that include
embedded measures from all 6 cognitive domains as well as free-standing PVTs. His sample
battery contains a total of 27 tests, 10 of which include EVIs, and recommends additional freestanding PVTs.
Careful consideration must be taken when deciding how many PVTs to use, how to
minimize the burden of additional PVTs, and which cutoff scores are appropriate for each
particular examinee (Rickards, Cranston, Touradji, & Bechtold, 2017). Although it is generally
agreed that a single PVT failure provides insufficient evidence to determine non-credible
performance, the exact number of PVT failures required to deem an entire neurocognitive profile
invalid varies across assessors. It has been argued that false positive risk increases substantially
with the number of PVTs given (Berthelson, Mulchan, Odland, Miller, & Mittenberg, 2013;
Bilder, Sugar, & Hellemann, 2014), whereas many contend the risk of false positives can be
reduced by responsibly adjusting cutoff scores or the number of PVT failures needed for the
profile to be considered invalid (Larrabee, 2014a; Odland, Lammy, Martin, Grote, & Mittenberg,
2015). Using multiple PVTs can increase sensitivity without reducing specificity because the
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probability of having multiple PVT failures is low (Jasinski et al., 2011; Victor, Boone, Serpa,
Buehler, & Ziegler, 2009). In fact, Larrabee (2014a) argued that multivariate models of
performance validity assessment can protect against false positive errors.
A final consideration when determining the likelihood of invalid performance may be the
level of failure. This is particularly true in a forced-choice paradigm. For example, if an
individual answers 15% of the items correctly, a performance well-below chance level
responding on the TOMM, the score can be confidently interpreted as non-credible (Slick &
Sherman, 2012). Rickards, Cranston, Touradji, and Bechtold (2017) offered a systematic
approach to PVT administration by creating a decision tree for neuropsychologists to follow
when deciding whether or not to administer additional PVTs to determine credibility. The
authors suggest that several factors should be considered when evaluating performance
credibility including identification of risk groups (incentive, referral type, patient population),
behavioural observations (non-credible symptom endorsement, inconsistencies in self-reports),
and PVT and symptom validity outcomes.
In summary, in order to minimize the likelihood of a false positive error,
neuropsychologists should utilize multiple independent tests (both embedded and free-standing)
with high sensitivity and specificity that cover a variety of cognitive domains. Tests should be
interpreted in the context of the overall evaluation and assessors should ensure that the PVT
cutoffs used are appropriate for the population. To the best of our knowledge, no research has
been conducted on PVT use in a population with HIV-associated neurocognitive disorders
(HAND).
HIV-Associated Neurocognitive Disorders
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HAND is cognitive dysfunction secondary to human immunodeficiency virus (HIV)
infection. As many as 50% of HIV-positive (HIV+) individuals have neurocognitive impairment,
which is associated with unemployment and reduced independence in daily living (Heaton,
Marcotte, et al., 2004, 2010). Further, neurocognitive dysfunction in individuals with HIV
increases mortality risk (Ellis et al., 1997).
Frascati criteria. In 1991, the American Academy of Neurology proposed the diagnosis
of HAND be divided into two subtypes based upon the severity of cognitive and daily living
impairments (Janssen et al., 1991). However, this subdivision was imprecise and insufficient as it
did not specify criteria (i.e. the extent of impairment) nor did it allow for the diagnosis of
patients with cognitive but not functional impairments. To address these shortcomings, the HIV
Neurobehavioural Research Center proposed a new way to categorize the HAND diagnosis, now
known as the Frascati criteria. This group identified three distinct categories: HIV-associated
dementia (HAD), HIV-associated mild neurocognitive disorder (MND), and asymptomatic
neurocognitive impairment (ANI; Antinori et al., 2007). To be classified into any of the three
categories, differential diagnoses and comorbidities must be ruled out as the principal etiology
for neurocognitive deficits.
HIV-associated dementia. Individuals with severe cognitive and functional impairments
are diagnosed with HAD. To be placed in this category, patients must perform 2 standard
deviations (SD) below the normative mean on two neurocognitive domains. They must also
indicate moderate-to-severe levels of impairment in daily living, as assessed by self- or
informant- reports, or be impaired on standardized measures of activities of daily living (Antinori
et al., 2007). Although the number of HAND cases persists (Heaton et al., 2010), the incidence
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of HAD has declined since the introduction of combination antiretroviral therapy (cART) to HIV
treatment (Sacktor et al., 2002).
The cognitive impairment in HAD has been associated with reduced glutamate and
glutamine levels within the frontal white matter, which may be indicative of neuronal
dysfunction (Mohamed et al., 2010). Patients with HAD perform poorly on verbal fluency tasks,
producing a greater number of errors and fewer total words than a non-demented HIV+ sample
(Woods, 2004). On auditory learning and memory tests, words from the end of the list are
overrepresented in HAD patients. This pronounced recency effect is commonly interpreted as an
emergent sign of severe memory deficit, as the examinee is compensating for impaired encoding
and consolidation skills by increasingly relying on auditory attention/echoic memory – cognitive
domains that are relatively robust to the deleterious effects of neurodegenerative diseases (Scott
et al., 2006).
Mild neurocognitive disorder. Individuals whose cognitive deficits lead to mild
impairments in daily living are categorized as having MND. In order to meet the recommended
criteria, a patient must score 1 SD below the normative mean in at least two cognitive domains.
Mildly impaired daily living includes reports of diminished independence, accuracy, or
efficiency in adaptive or occupational functioning, operationalized as a score 1 SD below
normative means on standardized functional tests, and/or informant-/ self- reports of requiring
assistance in 2 cognitive domains or activities (Antinori et al., 2007).
Asymptomatic neurocognitive impairment. The ANI classification allows for the
objective diagnosis of patients presenting with cognitive dysfunction but no impairment in daily
living. Similar to MND, the patient must score 1 SD below the normative mean in 2 cognitive
domains but does not meet the remaining criteria of MND and HAD (Antinori et al., 2007). Over
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half of those diagnosed with HAND only meet the criteria for ANI. This finding is consistent
across geographic regions including Brazil (de Almeida et al., 2017), Korea (Ku et al., 2014),
and China (Zhao et al., 2015).
Prognosis. The prognosis of HAND fluctuates over time and across cases. Over one year,
only 58% of patients had stable cognitive performance, while the remaining 42% either
worsened, improved, or oscillated between the two (Antinori et al., 2007). If a patient’s cognitive
performance improves to the point that their HAND categorization is no longer appropriate, the
specifier “in remission” may be added. cARTs appear to increase performance in several
cognitive domains and improve prognosis up to 4 years after treatment initiation (Kore et al.,
2015; Robertson et al., 2012; Willen, Cuadra, Arheart, Post, & Govind, 2017).
Ultimately, cognitive changes are difficult to predict and a patient’s neurocognitive
ability should be continually monitored (Kamminga et al., 2017). Neurocognitive impairment has
been associated with a variety of variables including lower cluster of differentiation 4 (CD4)
counts, cART, cerebral spinal fluid HIV ribonucleic acid, smoking, neuropathy, substance use,
stress, and body mass index (Akhtar-Khaleel et al., 2017; Chang, Lim, Lau, & Alicata, 2017;
Cohen et al., 2011; Fellows et al., 2012; Gustafson et al., 2013; Keen & Turner, 2014; Kinuthia,
Thigiti, & Gakinya, 2016; Kore et al., 2015; Muñoz-Moreno et al., 2008, 2013; Rubin et al.,
2015). Further, cytokine levels within the cerebral spinal fluid have been associated with slowed
psychomotor speed and impaired executive functioning (Nolting et al., 2012). More specifically,
high interleukin 6 levels have been linked to reduced processing speed abilities as demonstrated
by impairments on the Symbol-Digit Modalities Test (SDMT) and Trail Making Test (TMT;
Keen & Turner, 2014; Lake et al., 2015).
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Diagnosis. In order to categorize a HAND patient, a clinician must determine the
presence and severity of their neurocognitive dysfunction. The 3 screening tools measuring
neurocognitive deficits in HAND are traditional neuropsychological testing, the CogState
computerized battery, and the demographically adjusted HIV dementia scale (HDS; Kamminga
et al., 2017). However, only neuropsychological measures and the CogState battery have a
sensitivity and specificity above .70 for detecting HAND (Cysique, Maruff, Darby, & Brew,
2006; de Almeida et al., 2017; Moore et al., 2012). Further, the CogState battery has been
developed as a research tool and has not been validated for clinical use. Therefore, the gold
standard for cognitive testing in HAND research and clinical assessment is a neuropsychological
battery (de Almeida et al., 2017; Kamminga et al., 2017).
Some limitations of neuropsychological tests include their cost (clinician time, test
material) and dependence on appropriate norms. When determining a patient’s relative standing
compared to a strategically selected comparison group, it is important that relevant demographic
variables known to influence test performance (age, education, and gender) are accounted for.
Equally important are ethnic and racial background, with one study finding 71% of HIV+
African Americans were considered cognitively impaired when using the Caucasian norms, but
this number was reduced 45% when using African American norms (Antinori et al., 2007).
Similarly, once psychosocial and environmental factors were accounted for, group differences in
executive functioning between HIV+ and HIV- children diminished (Llorente et al., 2014).
Taken together, these studies emphasize the role of demographic factors in neuropsychological
test outcomes and highlight the need of appropriate norms.
Neurocognitive testing. Antinori and colleagues (2007) outlined 7 domains of interest in
neuropsychological testing, specifying that at least 5 domains should be examined prior to
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HAND classification: attention, language, executive functioning, motor skills, memory/learning,
processing speed, and sensory-perceptual abilities. The authors further specify that at least one of
the deficits must be cognitive in nature, eliminating the diagnosis if deficits are only observed in
sensory-perceptual and motor areas. There are a variety of tests that could be used to examine the
six domains but some of the most common ones include the Hopkins Verbal Learning Test –
Revised (HVLT-R), Grooved Pegboard Test (GPB), SDMT, TMT, Wisconsin Card Sorting Test
(WCST), and verbal fluency measures (de Almeida et al., 2017; Eggers et al., 2017; Gomez,
Power, Gill, & Fujiwara, 2017; Zhao et al., 2015). Following the introduction of cARTs to HIV
treatment, the primary pattern of cognitive impairment shifted from reduced psychomotor and
cognitive speed to impaired memory and executive functioning (Heaton et al., 2011). Still,
impairments occur in all domains of interest within this population and should be assessed using
a comprehensive battery of neuropsychological tests.
Within the HIV+ population, verbal learning and memory are commonly measured using
the HVLT-R. Women with HIV have significantly reduced performance on total learning and
delayed recall (Spies, Fennema-Notestine, Archibald, Cherner, & Seedat, 2012; Woods et al.,
2005). Interestingly, the HVLT-R has been identified as one of the most sensitive indicators of
HAND and, as such, has been included in several brief screening batteries. When a two-test
battery is used, the combination of HVLT-R total recall and non-dominant hand GPB T-score
<40 had .78 sensitivity and .85 specificity (Carey et al., 2004). The combination of HVLT-R and
the Stroop test T-score <40 on both or <35 on one of the tests had a sensitivity of .73 and a
specificity of .83. (Moore et al., 2012).
The GPB is a measure of fine motor functioning and psychomotor speed. HIV-associated
deficits in motor skills may relate to desynchronization between primary motor cortex and
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supplementary motor areas (Wilson et al., 2013) and/or grey matter atrophy within the basal
ganglia (Küper et al., 2011).
Within an HIV+ population, SDMT and the number-sequencing trial of the TMT (TMTA; D-KEFS Trails 2) is used to measure processing speed. HIV+ women perform worse on the
SDMT total correct compared to HIV- controls even after education, age, ethnicity, and reading
level are accounted for (Manly et al., 2011). In an HIV+ East Indian cohort, impaired
performance on the TMT and SDMT was unaffected by illness duration during the early stages
of the disease (Mandal et al., 2008). Impairments on these tests are not as severe in patients with
intact immunological functioning and suppressed viral load, suggesting that low scores may be a
consequence of the breakdown of immune systems in HIV (Cole et al., 2007). Interestingly,
physical activity appears to protect against the deleterious effects of HIV on neuropsychological
tests measuring attention (Monroe et al., 2017).
Executive functions in an HIV+ population is typically measured using the WCST and
the letter-number sequencing trial on the TMT (TMT-B; D-KEFS Trails-4). Compared to HIVcontrols, performance on both tests is impaired in HIV+ patients, with the greatest impairments
seen in those with acquired immunodeficiency syndrome (AIDS; Basso & Bornstein, 2003;
Moradi, Miraghaei, Parhon, Jabbari, & Jobson, 2012). Further, compared to demographically
matched controls, individuals perinatally infected with HIV have lower D-KEFS Trails-4
performance (Willen, Cuadra, Arheart, Post, & Govind, 2017). Performance on the TMT-B
appears to decline much more rapidly over time in older adults with HIV than those without,
suggesting that being HIV+ accelerates age-related cognitive decline (Sacktor et al., 2010).
Executive functioning impairments on the WCST in an HIV+ sample have been correlated with a
reduced caudate nucleus volume (Corrêa et al., 2016).
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Finally, letter and category fluency are commonly used to measure verbal abilities in an
HIV+ samples (Cysique et al., 2011). HIV+ status does not appear to dramatically impair
performance on verbal fluency tests (Thames et al., 2016). A meta-analysis of available literature
found the effect size for impairments due to HIV are small and similar between letter and
category fluency tests (Iudicello et al., 2008). Still, HIV is associated with psychometrically
detectable word generation deficits (Iudicello et al., 2007, 2008).
Performance validity. As mentioned, neuropsychological test performance can be
influenced by a variety of factors outside an examinee’s cognitive ability and several potential
confounds may be present in an HIV+ population. Seventy-three percent of HIV+ patients have
been classified as having a sleep disturbance according to the Pittsburgh Sleep Quality Index.
Insomnia was particularly common among individuals with cognitive impairments (Rubinstein &
Selwyn, 1998). The findings of a meta-analysis conducted in 2015 found that 58% of HIV+
patients had self-reported sleep disturbances. Across populations, North America had the greatest
prevalence of sleep disturbances in this population, reaching over 70% (Wu, Wu, Lu, Guo, & Li,
2015). The North American HIV+ population also has high levels of self-reported pain (Lawson
et al., 2014). A systematic review of 61 studies found the prevalence of pain ranged between
54% to 83% and was most commonly of moderate-to-severe intensity (Parker, Stein, & Jelsma,
2014). The relationship of PVTs with sleep and pain within the literature is inconsistent. For
example, in traumatic brain injury (TBI) sleep appears to have no effect on performance validity
(Dean & Sterr, 2013). However, PVT outcome has been shown to correlate with sleep and pain
in individuals with fibromyalgia (Johnson-Greene, Brooks, & Ference, 2013). Further, PVT
BRFail was as high as 50% in individuals with chronic regional pain syndrome type 1 in litigative
settings (Greiffenstein, Gervais, Baker, Artiola, & Smith, 2013). Further, individuals with HIV
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also report symptom and emotional distress (Jaggers et al., 2014; Pereira, Fialho, & Canavarro,
2014). Importantly, there is a high level of apathy in HIV+ patients (McIntosh, Rosselli, Uddin,
& Antoni, 2015). Taken together, all of these comorbid symptoms associated with HIV may
increase the likelihood of non-credible responding in HIV+ populations during
neuropsychological testing.
Research aimed at understanding what the typical PVT profile looks like in an HIV+
population will facilitate the detection of non-credible response sets. Developing a psychometric
method for differentiating valid and invalid profiles would allow clinicians and researchers to
determine with greater confidence whether low scores on neuropsychological tests, and the
corresponding HAND diagnosis, reflect true impairment or non-credible performance. As stated
earlier, 42% of patients have changes in their neurocognitive performance over a 1-year time
span (Antinori et al., 2007). Part of this may reflect fluctuations in performance validity.
Therefore, research aimed at understanding performance validity in the HIV+ population has
important psychometric implications that could improve diagnostic certainty and disease
management.
Objective
The overarching objective of this study is to assess performance validity in an HIV+
sample. To achieve this objective, archival HIV+ patient performance was compared to
prospectively-collected undergraduate scores on EVIs contained within a HAND battery. To the
best of our knowledge, the present study is the first to explore PVTs in an HIV+ sample. There
were four groups within the HIV+ sample, those identified as neurocognitively normal (NN) and
those diagnosed with ANI, MND, or HAD. EVI scores were compared between these four
groups as well as to an undergraduate sample. Undergraduate participants were assigned to either
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a control condition, where they were asked to try their best, or an experimental malingering
condition (EXPMAL), where they were instructed to feign neurocognitive deficits. Therefore, a
total of six groups existed within this study: NN, ANI, MND, HAD, controls, and EXPMAL.
In the first part of the study, we compared the BRFail across groups – both on individual
measures and the cumulative failure rates (i.e., number of individuals who failed ≥1, ≥2, ≥ 3, ≥ 4,
and ≥5 PVTs). We hypothesized that EXPMAL would have the highest BRFail as they are
instructed to intentionally perform below their true ability. Additionally, we hypothesized that
the level of EVI failure in EXPMAL would not differ from the HAD sample because dementia
samples are prone to highly elevated BRFail on measures of performance validity (Davis, 2018).
The next highest BRFail was expected in the MND and ANI samples. As certain EVIs have been
shown to be sensitive to genuine cognitive impairments, this population was expected to have a
higher BRFail than NN or controls. Lastly, we anticipated no BRFail difference between NN and
controls. It is worth noting that these two groups were not matched for demographic variables.
As with all undergraduate samples, we expected them to represent a unique set of demographic
variables (young, educated, high functioning) difficult to generalize to the general population.
However, because EVIs are believed to be insensitive to the majority of demographic variables,
and it is assumed that both groups are performing to their true ability, no significant differences
were anticipated. In summary, we hypothesized the following gradient of BRFail:
EXPMAL = HAD > MND = ANI > NN = control
In order to develop a more thorough understanding of how invalid performance might
impact scores on cognitive tests within HIV+ individuals, members of the MND, ANI, and NN
groups were merged and then divided according to the total number of EVIs failed. The
relationship between the number of EVIs failed and the examinee’s neuropsychological test
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scores were then investigated. We hypothesized a strong negative linear relationship between
number of EVI failures and performance on neuropsychological tests.
For the final part of our study, we examined the relationship between emotional
functioning and performance validity. The MND, ANI, NN, and control group were merged and
participants were regrouped according to their overall Patient Health Questionnaire (PHQ-9)
scores. PHQ-9 scores were then compared to the number of EVIs failed to determine whether
they may be a predictor of performance validity. It was hypothesized that those with higher
PHQ-9 scores would have a greater number of EVI failures.

19

CHAPTER II
Methods
Participants
Sample 1: HIV+. The first sample was archival, using the data collected by Gomez,
Power, Gill, and Fujiwara (2017). Their original research question asked whether risk-based
decision making in an HIV+ sample correlated with a number of variables including
neurocognitive performance. In the following section, a description of their cohort and
methodology is provided.
Recruitment. All participants were diagnosed with HIV and recruited from the Southern
Alberta Clinic (SAC) in Calgary, Alberta, Canada. Testing was completed between May 2013
and January 2016. All participants had normal or corrected-to-normal vision and hearing.
Further, they all had sufficient English fluency and were capable of providing informed consent.
Demographic variables. Gender, sexual orientation, current/nadir CD4 and T-cell count,
current/peak plasma HIV viral load, psychiatric and medical comorbidities, duration of HIV
infection, cART status, cART side effects and polypharmacy, and cART regimen central nervous
system (CNS)-penetration effectiveness rank were collected via chart review. The participant’s
age, ethnicity, country of origin, years of education, hepatitis C coinfection, and past/present
substance use were collected via chart review and followed-up during the interview. Finally,
cART adherence within the previous 5 days as well as perceived health and daily functioning
were assessed during the interview.
HAND diagnosis. The “Frascati criteria” were used to determine HAND status.
Diagnoses were further verified using the participant’s medical record. HAND status could not
be obtained if the participant had a history of head trauma with loss of consciousness exceeding
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5 minutes, severe psychiatric or neurological disorders, or opportunistic CNS infection. At the
time of testing, the participants spoke English fluently, and had greater than 9 years of education.
Number of participants. A total of 291 participants were enrolled in the study, 64 with
neurocognitive impairments classified as HAND (25 ANI, 31 MNI, 8 HAD) and 227 NN.
Ethics approval. Data set collection was approved by the University of Calgary Conjoint
Health Research Ethics Board (ethics ID: REB13-0615_REN2). All participants consented for
their data to be used for research purposes. Ethical approval was also received from the
University of Windsor Research Ethics Board.
Sample 2: Undergraduates. The second group of participants were prospectively
collected undergraduates. The student sample provided control and EXPMAL groups.
Recruitment. Undergraduate students were recruited from the University of Windsor
Psychology Participant Pool. One screening question was asked prior to viewing the recruitment
posting: “Are you 18 years of age or older?”. If the answer was YES, the student was able to
view the recruitment posting. The recruitment posting asked that participants identify as HIVprior to signing up for the study. An email reminder was sent to students signed up for the study
48 hours prior to testing and a 24-hour cancellation notice was set. In order to optimize testing
conditions, participants were asked to bring their glasses/contacts and/or hearing aid to the
appointment. The battery took approximately 120 minutes to complete and participants received
2.5 credits for their involvement.
Inclusion criteria. All participants were 18 years of age or older and reported that they
were HIV-.
Number of participants. A total of 74 undergraduate participants were recruited for the
study. Two students were assigned to the control condition for each student assigned to EXP MAL
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(2 controls: 1 EXPMAL). Only controls were included within the majority of our hypotheses, thus
we wanted to maximize the sample size of this condition. Further, the 2:1 ratio was identified by
G*Power as sufficient to observe group differences if they exist (Faul, Erdfelder, Lang, &
Buchner, 2007). In total, fifty-one participants were randomly assigned to the control condition,
while the remaining 23 were assigned to EXPMAL.
Measures
Gomez, Gill, Power, and Fujiwara (2017). All testing was completed in a quiet,
distraction-free room located in the SAC. After giving informed consent, neuropsychological
testing followed a brief interview. All testing was completed by a trained researcher at the clinic.
HAND battery. The format of the HIV+ neurocognitive assessment was as follows: brief
interview, D-KEFS verbal fluency (FAS/animals/boys names), Wide Range Achievement Test 4
(WRAT-4) Reading, Game of Dice, HVLT-R (learning trials 1-3, recognition trial), SDMT,
WCST (64 cards), D-KEFS Trails 2 and 4, GPB (dominant hand, non-dominant hand), PHQ-9,
HVLT-R (delayed recall).
Prospective undergraduate sample. The measures and procedures selected to be used in
the undergraduate sample aimed to replicate the Gomez, Gill, Power, and Fujiwara (2017) study
as closely as possible. However, the Game of Dice was removed as it adds to administration
time, is an experimental measure without statistical norms, and is not involved in our research
questions. One free-standing PVTs (WCT) was added to the battery to improve the classification
accuracy of undergraduate participant profiles as valid or invalid (Iverson, Franzen, &
McCracken, 1994).
Test administration. Testing was completed in a quiet, distraction-free room in the
University of Windsor. Informed consent was obtained from all participants prior to
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psychometric testing. Participants completed a brief questionnaire in order to obtain basic
demographic information. Neuropsychological testing followed. All participants were fully
debriefed following testing. The test sequence was as follows: brief interview, WCT
(counterbalanced; either at the beginning or end of battery), WRAT-4 Reading, D-KEFS verbal
fluency (FAS/animals/boys names), HVLT-R (learning trials 1-3), SDMT, D-KEFS Trails 2 and
4, GPB (dominant hand, non-dominant hand), HVLT-R (delayed recall, recognition), PHQ-9,
and WCT (counterbalanced; either at the beginning or end of battery).
Demographic variables. Basic demographic information was collected during the
questionnaire (e.g. gender, age, handedness, and years of education). Psychiatric and
neurological histories were also collected (Appendix A).
Experimental malingering & control conditions. Undergraduates were randomly
assigned into one of two conditions: EXPMAL or control. Following the brief interview,
participants were given a sealed envelope containing instructions on how to perform for the
remainder of the experiment. Envelopes were quasi-counterbalanced to ensure random group
selection. The envelope was used to prevent the researcher conducting the experiment from
knowing the participant’s condition and potentially biasing results. The instructions to controls
requested they put forth their best effort while completing all tests. In contrast, participants in the
EXPMAL condition received detailed instructions on how to feign cognitive deficits in a pattern
similar to that following a moderate to severe TBI. The given scenario has been previously used
within our lab and was modelled after scenarios developed by DenBoer & Hall (2007) and Suhr
& Gunstad (2000; Appendix B). The recommendations for simulation studies provided by
Rogers (2008) were adhered to. Following the end of testing, a manipulation check was
completed (Appendix C).

23

WRAT-4. Similar to the original study, participants completed the WRAT-4 Reading
subtest. The WRAT-4 Reading subtest (blue version) is a list of 55 words, ordered according to
difficulty, which the participant must read aloud. Pronunciation was scored as correct or
incorrect (Wilkinson & Robertson, 2006).
PHQ-9. The PHQ-9 is a brief questionnaire measuring self-reported depressive
symptoms over the past two weeks (Kroenke, Spitzer, & Williams, 2001).
Performance validity tests. D-KEFS verbal fluency, D-KEFS Trails, WCST, GPB, and
HVLT-R all contain EVIs. Therefore, a total of 8 EVIs included within the original HAND
battery were analyzed and tested in undergraduates (Table 1). The EVIs span a variety of
cognitive domains and include both verbal and non-verbal measures. Conservative and liberal
cutoff scores were chosen for each test to optimize specificity or sensitivity, respectively.
Conservative cutoff scores aimed to have  .90 specificity whereas liberal cutoff scores had
improved sensitivity at the expense of slightly reduced specificity ( .84) (Boone, 2013;
Larrabee, 2003).
Table 1
Neurocognitive Testing Battery
Name
Abbreviation
Letter Fluency
FAS
Category Fluency
Animals
WRAT-4 Reading
WRAT-4 Reading
HVLT-R
HVLT-R
Symbol Digit
SDMT
WCST 64 Card
WCST-64
Modalities
Test
D-KEFS Trails
T2 & T4
Version Pegboard
Grooved
GPB
PHQ-9
PHQ-9

EVI
Yes
Yes
No
Yes
No
Yes
Yes
Yes
No

Reference
Delis, Kaplan, & Kramer, 2001
Delis, Kaplan, & Kramer, 2001
Wilkinson & Robertson, 2006
Brandt & Benedict, 2001
Smith. 1973
Kongs, Thompson, Iverson, &
Heaton,
2000 & Kramer, 2001
Delis, Kaplan,
Trites, 1977
Kroenke, Spitzer, & Williams, 2001

D-KEFS letter fluency. Participants were instructed to generate as many words as they
could think of beginning with a specific letter (F, A, and S ) in 60 seconds following some basic
rules (cannot use proper names, numbers or the same word with different suffix; Delis, Kaplan,
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& Kramer, 2001). Many of the EVIs within FAS are typically based on demographically
adjusted T-scores (Curtis, Thompson, Greve, & Bianchini, 2008; Sugarman & Axelrod, 2015),
which differ from age corrected scaled scores (ACSS) in the D-KEFS norms. Thus, raw scores
were converted to T-scores using demographically adjusted norms by Heaton, Miller, Taylor, &
Grant (2004). DelisSugarman and Axelrod (2015) found that an FAS T-score of ≤ 31 produced
.90 specificity and .30 sensitivity, while an animal cutoff of T ≤ 33 had a .91 specificity and .42
sensitivity. Similarly, Curtis, Thompson, Greve, & Biachini (2008) suggested cutoff scores of ≤
31 (.95 specificity, .27 sensitivity) and ≤33 (.90 specificity, .36 sensitivity) on FAS.
D-KEFS category fluency. Following the same structure as letter fluency, category
fluency required the participant to list as many animals and boys names as they can within 60
seconds (Delis et al., 2001). Sugarman and Axelrod (2015) suggested a conservative raw score
cutoff of ≤12 (sensitivity: .50; specificity: .90) and a liberal raw score cutoff of ≤ 13 (sensitivity:
.55; specificity: .84) on animal fluency. The combined total of both categories was converted to
an ACSS and used as a measure of cognitive ability.
HVLT-R. This is a test of auditory verbal learning and memory. Participants listened to a
list of 12 words and were asked to recall as many as they could after each trial. For the purposes
of our testing, three acquisition trials and a Yes/No recognition trial were administered (Brandt
& Benedict, 2001). One study has published EVI cutoffs for the discrimination trial. They found
correct responding during the discrimination trial  5 has a sensitivity of .93 but a specificity of
.53, while the number of correct responses being  6 has a sensitivity of .74 and specificity of .84
(Sawyer, Testa, & Dux, 2017).
WCST. This test is a measure of concept formation and cognitive flexibility. Participants
were asked to match each card, handed one at a time, to one of four key cards. Each card
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contains 3 salient features (colour, form, number; Kongs, Thompson, Iverson, & Heaton, 2000).
In the full 128 card version, FMS and the number of categories completed were included into a
logistic regression equation that successfully differentiated credible from non-credible
performance (Suhr & Boyer, 1999). FMS on the WCST is relatively insensitive to TBI and
executive deficits in both adults (Heaton, Chelune, Talley, Kay, & Curtis, 1993; Jodzio &
Biechowska, 2010) and children (Lichtenstein, Erdodi, Rai, Mazur-Mosiewicz, & Flaro, 2016).
In contrast to healthy undergraduates and those with credible TBI, experimental malingerers and
patients with TBI seeking compensation had more than double the number of FMS errors (≥ 2;
King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Suhr & Boyer, 1999). Larrabee (2003)
reported .87 specificity and .48 sensitivity for FMS errors ≥ 2. Across a variety of non-litigating
clinical populations, the mean FMS was consistently <1. However, FMS as an EVI has been
calibrated using the 128-card version but the current study used the 64-card version. As such, the
theoretical probability of FMS errors is lower (half). Therefore, at conventional cutoffs, the FMS
in the 64-card version is expected to have higher specificity.
D-KEFS Trails 2 and 4. When completing Trail 2, examinees were instructed to connect
circles containing numbers in increasing order using a pencil. Trail 4 requires letter-number
sequencing: when connecting letters to numbers, examinees are asked to alternate between
numbers in increasing and letters in alphabetical order. Trail 2 measures processing speed and
simple visual attention. Trail 4 measures cognitive flexibility and divided attention (Delis et al.,
2001). Although the original Trail Making Test has been validated as a PVT (Busse &
Whiteside, 2012; Iverson, Lange, Green, & Franzen, 2002; Ruffolo, Guilmette, & Willis, 2000;
Shura, Miskey, Rowland, Yoash-Gantz, & Denning, 2016), there has been no research exploring
the utility of D-KEFS TMT in detecting non-credible performance. Our research group recently
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investigated the potential of D-KEFS Trails to function as EVIs (Erdodi, Hurtubise, et al., 2018).
We found that a Trails 2 ACSS cutoff of 5 met minimum specificity standards (.85 - .88) with a
sensitivity of .43-.57. At the more conservative cutoff of 3, specificity improved (.87-.93) at
the expense of sensitivity (.26-.38). On Trails 4, cutoffs of 4 (specificity: .88, sensitivity: .45.57) and  1 (specificity: .90-.93, sensitivity: .27-.48) produced good combinations of specificity
and sensitivity.
Grooved Pegboard. This test is a measure of fine motor speed and requires participants to
rotate pegs into peg holes using their dominant and, later, their non-dominant hand. Speed and
the number of pegs dropped were recorded (Trites, 1977). A dominant hand T-score cutoff  29
produced a sensitivity of .61 and a specificity of .90 when groups were classified according to
performance on the words subtest of the Warrington’s Recognition Memory Test and two other
composite measures of performance validity. In contrast, a dominant hand T-score cutoff of  25
had a sensitivity of .52 and a specificity of .96. The same cutoffs produced good combinations of
sensitivity and specificity for the non-dominant hand (liberal: .65 and.89; conservative: .50 and
.96; Erdodi, Seke, et al., 2017).
Statistical Analysis
All statistical procedures were performed using Statistical Package for the Social
Sciences (SPSS) version 22.0. Descriptive statistics (mean, SD, range, skew, kurtosis) for
demographic variables were reported in all four groups. These variables were compared using a
t-test for continuous variables (e.g. age, education) and a chi-square test of independence for
categorical variables (e.g. gender). For all hypotheses, BRFail across groups was compared at
liberal and conservative cutoffs separately.
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Hypothesis 1: EVI failure will vary according to group membership (EXPMAL=
HAD > MND = ANI > NN = CON). It was expected that this prediction would remain true
regardless of whether the dependent variable was the total number of EVIs failed (continuous) or
BRFail (categorical: Pass/Fail). For each EVI, participants were scored as either passing or failing
according to the predetermined cutoff. Each participant received a total score of the number of
EVIs they failed. As this was a continuous variable with a maximum score of 8, a betweensubjects analysis of variance (ANOVA) was conducted and a comparison was made between the
six groups. Assumptions checked included normality, equal variance, and independence of
groups. Post-hoc contrasts were uncorrected post-hoc tests. An effect size estimate (Cohen’s d)
was computed for significant contrasts.
BRFail was compared between the six groups by looking at whether groups varied in the
number of individuals failing 1, 2, and ≥3 EVIs at the liberal cutoffs and 2, 3, and ≥4 EVIs at
the conservative cutoffs. These analyses were done to compare proportions between groups. To
allow for easier clinical interpretation, risk ratios were computed, followed by 2 analysis to
determine statistical significance.
Hypothesis 2: Those failing a greater number of EVIs will perform more poorly on
neuropsychological tests. To test this hypothesis, the MND, ANI and, NN groups were merged
together and this large pool was divided according to the number of EVIs each participant failed.
All neurocognitive measures that doubled as EVIs were removed from this analysis to reduce the
effects of collinearity. For the purpose of our analysis, the independent variable had 3 levels at
the liberal cutoffs: 2 EVIs failed, 3 EVI failed, and 4 EVIs failed and 3 levels at the
conservative cutoffs: 1 EVIs failed, 2 EVI failed, and 3 EVIs failed. ANOVAs were
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conducted to compare the performance across these three groups on six measures of cognitive
ability.
Hypothesis 3: Regardless of HIV status, individuals who have elevated PHQ-9
scores will fail more EVIs than those who do not. Using their PHQ-9 scores, all participants
except the EXPMAL and HAD groups were divided into none (0), minimal (1-4), mild (5-9),
moderate (10-14), moderately severe (15-19), and severe ( 19) depression. In a manner similar
to Hypothesis 1, BRFail was conducted for 2, 3, and ≥4 EVIs at the liberal cutoffs and 1, 2, and
≥3 EVIs at the conservative cutoffs using a 2 analysis. Additionally, the total number of failed
EVIs between participants was calculated and compared between the six groups (none, minimal,
mild, moderate, moderately severe, and severe). As there were six groups to compare, an
ANOVA was conducted. An additional ANOVA was conducted assessing the relationship
between EVI failure and depressive symptom severity as indicated by question 10 on the PHQ-9
(not very difficult, somewhat difficult, very difficult, and extremely difficult).
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CHAPTER III
Results
Data Cleaning
Prior to data analysis, all relevant variables were scanned using descriptive statistics to
identify human error in data scoring or entry. All data were deemed acceptable. Within the HIV+
dataset, no cases were removed. A total of 9 cases were removed from the student dataset and
subsequent analysis. Of these, 2 were removed due to inadequate demographic information that
prevented comparison of their performance to age-matched controls. One participant in the
EXPMAL group reported “not pretending” to have a head injury or following instructions.
Additionally, 6 participants were excluded from subsequent analysis because they did not
complete all 8 EVIs. The final sample size was 346 participants.
Testing of Assumptions
Skewness and Kurtosis. T-tests and ANOVAs assume that data are normally distributed.
In order to test for the normal distribution of data, skewness and kurtosis values were assessed
for all continuous variables (e.g. FAS T-Score, Animals T-Score, Verbal Fluency Boys Names,
HVLT-R Total Learning, HVLT-R Delayed Recall, WCST Categories Completed, D-KEFS
Trails 2 and 4, GPB Dominant and Non-Dominant Hand, and PHQ-9 Total Score). None of the
variables produced skewness or kurtosis values outside the acceptable range of +2 and -2 (Pituch
& Stevens, 2016).
Equality of Variance. Equal variance across populations was tested using the Levene’s
Test of Equality of Variances for each variable and is reported below.
Independence of Observations. The only assumption of 2 test of independence is the
independence of observations. All groups contain greater than 5 cases and participants were
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placed into a single group. Further, it is not believed that the group membership of one
participant influenced the group membership of another.
Main Analyses
Demographic Variables. T-tests were conducted to determine whether demographic
differences exist between HIV+ and student participants. Overall, the undergraduate sample was
younger (Mstudent = 22.1, SDstudent = 5.0) than the HIV+ sample (MHIV+ = 47.4, SDHIV+ = 10.9;
t(354) = 28.45, p < .001, d = 2.98). The student sample had completed more years of education
(Mstudent = 14.6, SD student = 1.1) than those in the HIV+ dataset (MHIV+ = 14.1, SDHIV+ = 2.5;
t(354) = -2.42, p = .016, d = 0.26).
Sample differences in handedness and gender were assessed using 2 tests of
independence. Handedness did not differ between the two samples (2 = 3.51, p = .173). The
proportion of female and male participants varied between samples (2 = 158.6, p < .001), with a
greater proportion of female participants in the student (86.2%) than HIV+ (11.3%) sample.
Validating EVIs in the HAND Battery using a student sample. A total of eight
established EVIs were included within the HAND battery. Predetermined cutoffs, outlined in the
methods section, did not provide adequate sensitivity and specificity for the undergraduate
sample. Therefore, an exploratory analysis was conducted. Beginning with the proposed cutoffs,
the sensitivity and specificity of alternative cutoffs were also computed. The liberal and
conservative cutoffs used for hypothesis testing were those producing specificity nearest to .84
and .90 respectively (Table 2). Two criterion measures were used to determine sensitivity and
specificity: (1) EXPMAL vs. Controls and (2) WCT raw scores > 47 (pass) vs.  47 (Fail; Erdodi,
Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014; Pearson, 2009).
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Table 2
Liberal and Conservative Cutoffs for each EVI as determined by sensitivity and specificity of
each EVI against criterion PVT in the sample
EVI
Scale
Liberal
Conservative
HVLT-R RD
Raw score
≥8
≥7
WCST FMS
Raw score
≤2
≤1
D-KEFS Trail 2
ACSS
≥6
≥5
D-KEFS Trail 4
ACSS
≥7
≥6
GPB DOM
T-score
≥ 31
≥ 29
GPB ND
T-score
≥ 33
≥ 31
FAS
T-score
≥ 33
≥ 31
Animals
T-score
≥ 33
≥ 29
Note. EVI: Embedded Validity Indicator; HVLT-R RD: Hopkins Verbal Learning Test – revised recognition
discrimination (Sawyer, Testa, & Dux, 2017); WCST FMS: Wisconsin Card Sorting Test failure to maintain set
(King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999). D-KEFS T2 & T4:
Delis-Kaplan Executive Functioning System, Trails 2 and 4 (Erdodi, Hurtubise, et al., 2018); GPB DOM: Grooved
Pegboard Test dominant hand (Erdodi, Seke, et al., 2017); GPB ND: Grooved Pegboard Test non-dominant hand
(Erdodi, Seke, et al., 2017); FAS & Animals: Delis-Kaplan executive functioning system (Curtis, Thompson, Greve,
& Biachini, 2008; Sugarman & Axelrod, 2015).

Area under the curve (AUC) provides an objective measure of overall classification
accuracy (i.e. determining whether a profile is valid or invalid). AUC may be classified as
acceptable (.70-.79), excellent (.80-.89), or outstanding (≥ .90; Hosmer & Lemeshow, 2000).
With the exception of WCST FMS, all EVIs fell within or above the acceptable range (Table 3).
WCST FMS AUC values fell well below the acceptable level (.64) but within the acceptable
range (.75) when using the EXPMAL criterion and WCT as the PVT criterion, respectively. DKEFS T2, FAS, and Animals produced acceptable classification accuracy. HVLT-R RD and
GPB Dom had excellent classification accuracy. EVI classification varied depending on the
criterion measure used for D-KEFS T4 and GPB ND. D-KEFS T4 AUC acceptable classification
accuracy using the WCT and excellent classification accuracy when EXPMAL was the criterion
PVT. In contrast, excellent classification accuracy was observed with GPB ND using EXPMAL
criterion but outstanding accuracy with WCT as the criterion.
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Table 3
Area Under the Curve and Confidence Intervals of Select EVI Validity Cutoffs against Various
Criterion PVTs
Criterion PVT
EXPMAL
WCT
AUC
95% CI
AUC
95% CI
EVI RD
HVLT-R
.81
.69-.93
.88
.76-1.00
WCST FMS
.64
.48-.80
.75
.58-.91
D-KEFS T2
.79
.65-.92
.73
.58-.88
D-KEFS T4
.83
.72-.95
.75
.61-.89
GPB Dom
.82
.70-.94
.84
.73-.96
GPB ND
.80
.67-.92
.92
.83-1.00
FAS
.71
.57-.85
.70
.56-.84
Animals
.76
.63-.89
.76
.60-.92
Note. EVI: Embedded Validity Indicator; AUC: Area under the curve; 95% CI: 95% confidence interval; WCT:
Word Choice Test (Pass: WCT score > 47; Fail: WCT score 47 (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, &
Medoff, 2014; Pearson, 2009); HVLT-R RD: Hopkins Verbal Learning Test – Revised recognition discrimination
(Sawyer, Testa, & Dux, 2017); WCST FMS: Wisconsin Card Sorting Test failure to maintain set (King, Sweet,
Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999). D-KEFS T2 & T4: Delis-Kaplan
Executive Functioning System, Trails 2 and 4 (Erdodi, Hurtubise, et al., 2018); GPB DOM: Grooved Pegboard Test
dominant hand (Erdodi, Seke, et al., 2017); GPB ND: Grooved pegboard non-dominant hand (Erdodi, Seke, et al.,
2017); FAS: Letter fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015);
Animals: Category fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015).

Table 4 presents the sensitivity and specificity for the liberal and conservative cutoffs of
EVIs within the HAND battery. The classification accuracy for published cutoffs on seven of the
eight EVIs within the HAND battery hovered around the Larrabee limit: .50 sensitivity at .90
specificity (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014) against EXPMAL and
WCT as criterion measures. Specificity values were generally lower against the WCT than
EXPMAL. This pattern of findings is likely an artifact of differences in the BR Fail (21.9% vs.
32.3%). Overall, classification accuracy was similar across cutoffs between the two criterion
measures.
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Table 4
BRFail , Sensitivity and Specificity of Select EVI Validity Cutoffs against Various Criterion PVTs
Criterion PVTs
EXPMAL
WCT
SENS
SPEC
SENS
SPEC
EVI
Cutoff
BRFail
32.3
21.9
HVLT-R RD
≤8
17.2
.42
.96
.64
.96
≤7
14.1
.38
.98
.57
.98
WCST FMS
≥1
26.6
.43
.82
.64
.84
≥2
9.4
.24
.98
.29
.96
D-KEFS T2
≤6
26.6
.57
.89
.43
.78
≤5
14.1
.29
.93
.28
.90
D-KEFS T4
≥7
32.8
.67
.84
.50
.72
≥6
26.6
.67
.93
.50
.80
GPB Dom
≤31
31.3
.67
.86
.64
.78
≤29
23.4
.57
.93
.64
.88
GPB ND
≤33
29.7
.62
.86
.93
.88
≤31
23.4
.52
.91
.78
.92
FAS
≤33
23.4
.43
.86
.36
.80
≤31
18.8
.43
.93
.36
.86
Animals
≤33
20.3
.43
.91
.57
.91
≤29
14.1
.33
.95
.43
.94
Note. EVI: Embedded validity indicator; BRFail : Base rate of failure (% of the sample that failed a given cutoff);
WCT: Word Choice Test (Pass: WCT score > 47; Fail: WCT score 47 (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis,
& Medoff, 2014; Pearson, 2009); HVLT-R RD: Hopkins Verbal Learning Test – Revised recognition discrimination
raw score (Sawyer, Testa, & Dux, 2017); WCST FMS: Wisconsin Card Sorting Test failure to maintain set raw
score (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999). D-KEFS T2 & T4:
Delis-Kaplan Executive Functioning System, Trails 2 and 4 age-corrected scaled score (Erdodi, Hurtubise, et al.,
2018); GPB DOM: Grooved Pegboard Test dominant hand demographically adjusted T-score (Erdodi, Seke, et al.,
2017); GPB ND: Grooved Pegboard Test non-dominant hand demographically adjusted T-score (Erdodi, Seke, et
al., 2017); FAS: Letter Fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015);
Animals: Category Fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015)

To further quantify the utility of each EVI, t-tests were conducted to compare
performance for each criterion PVT (Table 5). Significant differences were observed between
controls and EXPMAL as well as between Pass and Fail of the WCT. Standard interpretation of
Cohen’s d suggests scores greater than .2 as small, greater than .5 as moderate, and greater than
.8 as large effect sizes. Only WCST FMS had an effect size in the small range (d = .28). The
remaining tests had moderate to large effects.
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Table 5
The Effect of Invalid Performance on Various EVIs in the Student Sample
Criterion PVTs
Experimental Malingering
WCT
EVI
IV
M
SD
t
p
d
WCT M
SD
t
p
d
HVLT-R RD NC 10.8 1.3 3.80 .001 1.12 † Pass 10.8 1.3 4.26 .001 1.60 †
EM 7.1 4.5
Fail
5.4 4.6
WCST FMS
NC .2
.5 -2.34 .028 .28 † Pass
.2
.7 -2.7 .014 .98 †
EM .9
1.2
Fail
1.1 1.1
D-KEFS T2
NC 9.8 2.7 4.47 <.001 1.10
Pass
9.2 3.2 2.89 .005 .84
EM 6.1 3.9
Fail
6.2 3.9
D-KEFS T4
NC 9.5 2.2 4.88 <.001 1.40 † Pass
8.8 2.9 2.79 .012 .87 †
EM 5.5 3.4
Fail
5.9 3.7
GPB Dom
NC 44.5 11.2 4.78 <.001 1.24
Pass 43.3 12.2 4.50 <.001 1.41
EM 29.9 12.3
Fail
27.2 10.5
GPB ND
NC 43.5 9.0 4.26 <.001 1.08
Pass 43.4 9.3 5.88 <.001 1.86
EM 32.3 11.6
Fail
27.2 8.1
FAS
NC 42.1 9.9 2.74 .008 .72
Pass 41.3 11.0 2.19 .032 .74
EM 34.8 10.3
Fail
34.4 7.4
Animals
NC 44.5 11.2 3.79 <.001 1.24
Pass 44.0 9.4 3.69 <.001 1.03
EM 29.9 12.3
Fail
32.9 12.0
Note. EVI: Embedded validity indicator; NC: Normal controls; EM: Experimental malingerer; WCT: Word Choice
Test (Pass: WCT score > 47; Fail: WCT score 47 (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014;
Pearson, 2009)); HVLT-R RD: Hopkins Verbal Learning Test – Revised recognition discrimination (Sawyer, Testa,
& Dux, 2017); WCST FMS: Wisconsin Card Sorting Test failure to maintain set (King, Sweet, Sherer, Curtiss, &
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999). D-KEFS T2 & T4: Delis-Kaplan Executive Functioning
System, Trails 2 and 4 (Erdodi, Hurtubise, et al., 2018); GPB DOM: Grooved Pegboard Test dominant hand
(Erdodi, Seke, et al., 2017); GPB ND: Grooved Pegboard Test non-dominant hand (Erdodi,Seke et al., 2017); FAS:
Letter fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Animals:
Category fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015).
†: Levene’s test of homogeneity of variance significant at p-value <.05

Although it is useful to understand each EVI individually, cumulative EVI failure\e is
more clinically relevant. For this reason, AUC and 95% confidence intervals were also
calculated by summing the total number of EVIs failed at liberal and conservative cutoffs (Table
6). Regardless of criterion PVT, liberal cutoffs produced excellent classification accuracy (.88.89). Although WCT AUC suggested acceptable classification accuracy using conservative
cutoffs (.78), the EXPMAL criterion suggested that it is outstanding (.92).
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Table 6
AUC and 95% CI of Select Levels of Failure against Various Criterion PVTs
Criterion PVT
EXPMAL
WCT
Number of EVI Failures
AUC
95% CI
AUC
95% CI
Liberal
.89
.79-.98
.88
.80-.98
Conservative
.92
.84-.99
.78
.76-.99
Note: EXPMAL: Experimental malingering condition; WCT: Word Choice Test (Pass: WCT score > 47; Fail: WCT
score 47 (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014; Pearson, 2009)); AUC: Area under the
curve; Liberal: EVIs failed at the liberal cutoff (Hopkins Verbal Learning Test – Revised recognition discrimination
(HVLT-R RD) ≤ 8; Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 2; Delis-Kaplan Executive
Functioning System (D-KEFS) Trail 2 ≤ 6; D-KEFS Trail 4 ≤ 7; Grooved Pegboard Test (GPB) dominant hand ≤
31; GPB non-dominant hand ≤ 33; FAS ≤ 33; Animals ≤ 33); Conservative: EVIs failed at the conservative cutoff
(HVLT-R RD ≤ 7; WCST FMS ≥ 1; D-KEFS Trail 2 ≤ 5; D-KEFS Trail 4 ≤ 6; GPB dominant hand ≤ 29; GPB nondominant hand ≤ 31; FAS ≤ 31; Animals ≤ 29).

BRFail, specificity, and sensitivity were calculated using cumulative failure cutoffs for
liberal and conservative EVIs (Table 7). As the number of EVIs failed increased, cutoffs
produced greater specificity at the expense of sensitivity. At the liberal and conservative cutoffs
of ≥4 and ≥3, respectively, sensitivity and specificity approached the Larrabee limit (Erdodi,
Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014). Again, specificity values were greater
when using EXPMAL as the criterion PVT rather than WCT.
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Table 7
Sensitivity and Specificity of the Cumulative EVI Failures at Select Cutoffs against Various
Criterion PVTs
Criterion PVT
EXPMAL
WCT
BRFail
32.3
21.9
Level of Cutoff
Number Failures
SENS SPEC
SENS SPEC
Liberal
≥1
67.7
.95
.46
1.00
.40
≥2
47.7
.86
.71
.93
.64
≥3
30.8
.81
.76
.79
.82
≥4
23.1
.57
.93
.64
.88
≥5
13.8
.43
1.00
.50
.96
Conservative
≥1
47.7
.95
.75
.93
.64
≥2
32.3
.91
.81
.80
.79
≥3
23.1
.57
.93
.71
.90
≥4
18.5
.48
.96
.57
.92
≥5
9.2
.29
1.00
.36
.98
Note: Embedded validity indicator; BR Fail : Base rate of failure (% of the sample that failed a given cutoff); EXPMAL:
Experimental malingering condition; WCT: Word Choice Test (Pass: WCT score > 47; Fail: WCT score 47
(Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014; Pearson, 2009); Liberal cutoffs (Hopkins Verbal
Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 8; Wisconsin Card Sorting Test failure to
maintain set (WCST FMS) ≥ 2; Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 6; D-KEFS Trail 4
≤ 7; Grooved Pegboard Test (GPB) dominant hand ≤ 31; GPB non-dominant hand ≤ 33; FAS ≤ 33; Animals ≤ 33);
Conservative cutoffs (HVLT-R RD ≤ 7; WCST FMS ≥ 1; D-KEFS Trail 2 ≤ 5; D-KEFS Trail 4 ≤ 6; GPB dominant
hand ≤ 29; GPB non-dominant hand ≤ 31; FAS ≤ 31; Animals ≤ 29).

EVI Failure and Group Membership. A between-subjects ANOVA was conducted to
determine whether the number of liberal and conservative EVIs failed differed between the six
groups (Table 8 and 9). The pattern of EVI failure was consistent between liberal and
conservative cutoffs. For both, post-hoc analysis identified that EXPMAL and HAD groups failed
significantly more EVIs than the other 4 groups but did not differ from each other. Those with
MND failed more EVIs than controls, NN, or ANI. ANI failed significantly more EVIs than
controls or NN. The number of EVIs failed did not differ between controls and NN.
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Table 8
Comparison of the total number of Liberal EVIs failed across groups
Total EVIs failed
n
M
SD
F
df
Control
44
1.0
1.2
50.58
5
EXPMAL
21
4.2
2.4
NN
227
0.82
0.9
ANI
25
1.6
1.4
MND
31
2.3
1.6
HAD
8
4.4
1.1

p
.000

p2
.42

Note. EVI: Embedded validity indicator; EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively
normal; ANI: Asymptomatic neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIVassociated dementia.

Table 9
Comparison of the total number of Conservative EVIs failed across groups
Total EVIs failed
n
M
SD
F
df
Control
44
0.5
1.0
60.33
5
EXPMAL
21
3.4
2.2
NN
227
0.4
0.6
ANI
25
1.0
0.9
MND
31
1.7
1.5
HAD
8
3.5
1.4

p
.000

p2
.46

Note. EVI: Embedded validity indicator; EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively
normal; ANI: Asymptomatic neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIVassociated dementia.

Table 10 presents the frequency distribution of the different profile validity
classifications across groups. Regardless of cutoff, the majority of controls, NN, ANI, and MND
participants produced valid profiles. In contrast, the majority of EXP MAL and HAD individuals
produced invalid profiles.
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Table 10
Profile Validity Distribution of All Participants by Group
Liberal
Valid
Borderline Invalid
Valid
Condition
n
(3)
(2)
(4)
(1)
Control
44
40
1
3
40
EXPMAL
21
4
5
12
5
NN
227
219
5
3
213
ANI
25
20
2
3
18
MND
31
19
6
6
18
HAD
8
0
2
6
1
Total
356
302
21
33
295

Conservative
Borderline
Invalid
(2)
(3)
1
3
4
12
12
2
6
1
4
9
1
6
28
33

Note. EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively normal; ANI: Asymptomatic
neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIV-associated dementia; Liberal cutoffs:
Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux,
2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, &
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning System (D-KEFS)
Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved
Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 33 (Erdodi, Seke,
et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Animals ≤ 33
(Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Conservative cutoffs: HVLT-R RD ≤ 7
(Sawyer, Testa, & Dux, 2017); WCST FMS ≥ 1 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee
2003; Suhr & Boyer, 1999); D-KEFS Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi,
Hurtubise, et al., 2018); GPB dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31
(Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015);
Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015).

Significant differences were observed between group membership and the proportion of
individuals failing EVIs at all liberal and conservative cutoffs investigated (Table 11 and 12).
Individuals in the EXPMAL and HAD groups were consistently more likely to fail than pass
cumulative EVI cutoffs, as indicated by risk ratios. In contrast, NN and controls were more likely
to pass than fail EVIs at all cutoffs.
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Table 11
Percentage of Failure, Risk Ratio, and 2 analysis of all groups at ≥2, ≥3, and ≥4 liberal EVIs
failed
Criteria
Condition
%
RR
p
2
2
≥2
Control
29.5
0.4
89.71
< .001
.25
EXPMAL
85.7
6.0
NN
17.6
0.2
ANI
52.0
1.1
MND
67.7
2.1
HAD
100.0
≥3
Control
9.1
0.1
146.72
< .001
.41
EXPMAL
76.2
3.2
NN
3.5
<.1
ANI
20.0
.3
MND
38.7
.6
HAD
100.0
≥4
Control
6.8
.1
119.66
<.001
.34
EXPMAL
57.1
1.3
NN
1.3
<.1
ANI
12.0
.1
MND
19.4
.2
HAD
75.0
3.0
Note. EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively normal; ANI: Asymptomatic
neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIV-associated dementia; Liberal cutoffs:
Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux,
2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, &
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning System (D-KEFS)
Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved
Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 33 (Erdodi, Seke,
et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Animals ≤ 33
(Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015).
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Table 12
Percentage of Failure, Risk Ratio, and 2 analysis of all groups at ≥1, ≥2, and ≥3 Conservative
EVIs failed
Criteria
Condition
%
RR
p
2
2
≥1
Control
25.0
.3
79.58
<.001
.22
EXPMAL
95.2
20
NN
29.1
.4
ANI
68.0
2.1
MND
77.4
3.4
HAD
100.0
≥2
Control
9.1
0.1
123.3
<.001
.35
EXPMAL
81.0
4.3
NN
6.2
.1
ANI
28.0
.4
MND
41.9
.7
HAD
87.5
7
≥3
Control
6.8
.1
132.9
<.001
.37
EXPMAL
57.1
1.3
NN
0.9
<.1
ANI
4.0
<.1
MND
29.0
.4
HAD
75.0
3
Note. EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively normal; ANI: Asymptomatic
neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIV-associated dementia; Conservative
cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 7 (Sawyer, Testa, &
Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 1 (King, Sweet, Sherer, Curtiss, &
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning System (D-KEFS)
Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018); Grooved
Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31 (Erdodi, Seke,
et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Animals ≤ 29
(Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015).

EVI Failure and Neuropsychological Test Performance. To test the influence of EVI
failure on neuropsychological test performance in the HIV+ population, the undergraduate
sample was removed. Further, the HAD group data was also removed as this population is
known to have severe and genuine impairment that would increase EVI failure and reduce test
performance (Davis, 2018). The remaining 4 groups (controls, NN, ANI, and MND) were
merged and regrouped according to the total number of liberal and conservative EVIs failed.
ANOVAs were conducted to explore group differences according to the total number of EVIs

41

failed (Table 13 and Table 14). Across all neuropsychological tests, the valid (liberal: ≤2;
conservative: ≤1) and invalid (liberal: ≥4; conservative: ≥3) profile groups performed differently,
with moderate to large effect sizes (d = .60-1.64). The borderline group (liberal: 3; conservative:
2) had significantly poorer performance than the valid group on verbal fluency categories,
HVLT-R total learning, HVLT-R delayed recall (liberal cutoff only), WCST categories
completed, and SDMT. Neuropsychological test performance between the borderline and invalid
groups never significantly differed.

Table 13
Comparison of Neuropsychological Test Performance across Levels of Liberal EVI Failure

NP Test
WRAT-4

Number of EVIs Failed
≤2
3
≥4
n = 258
n = 13
n = 12
M(91%)SD
M (5%)SD
M (4%)SD
105.0 12.7
94.8 14.1
91.4 13.1

F
10.03

p
<.001

ηp2
.07

VFlu Cat

10.9

3.3

6.9

3.4

6.3

2.7

20.14

<.001

.13

HVLT TL

42.1

10.8

31.0

6.5

29.9

7.7

13.81

<.001

.10

HVLT DR

41.7

12.6

29.8

12.7

30.1

11.1

9.97

<.001

.07

WCST Cat

3.3

1.4

2.1

1.4

2.4

0.8

7.55

.001

.05

SDMT

0.04

1.0

-1.4

1.2

-1.4

.8

22.94

<.001

.14

Sig. post hocs*
≤2 vs. 3
≤2 vs. ≥4
≤2 vs. 3
≤2 vs. ≥4
≤2 vs. 3
≤2 vs. ≥4
≤2 vs. 3
≤2 vs. ≥4
≤2 vs. 3
≤2 vs. ≥4
≤2 vs. 3
≤2 vs. ≥4

Note. EVI: Embedded validity indicator; WRAT-4: Wide Range Achievement Test – reading subtest scaled score
(Wilkinson & Robertson, 2006); VFlu Cat: Verbal fluency categories scaled score (Delis, Kaplan, & Kramer, 2001);
HVLT DR: Hopkins Verbal Learning Test - Revised delayed recall T-score (Brandt & Benedict, 2001); HVLT TL:
Hopkins Verbal Learning Test - Revised total learning T-Score (Brandt & Benedict, 2001); WCST Cat: Wisconsin
Card Sorting Test categories completed (Kongs, Thompson, Iverson, & Heaton, 2000); SDMT: Symbol Digit
Modalities Test z-score (Smith. 1973); Liberal cutoffs: Hopkins Verbal Learning Test – Revised recognition
discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain
set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999);
Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4
≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017);
GPB non-dominant hand ≤ 33 (Erdodi, Seke, et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008;
Sugarman & Axelrod, 2015); Animals ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod,
2015).
* Least significant difference (uncorrected t-tests)
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d
.77
1.01
1.21
1.56
1.24
1.30
1.02
1.07
.91
.81
1.29
1.57

Table 14
Comparison of Neuropsychological Test Performance across Levels of Conservative EVI Failure

NP Test
WRAT-4
VFlu Cat

Number of EVIs Failed
≤1
2
≥3
n = 249
n = 22
n = 12
(88%)
(8%)
(4%)
M
SD
M
SD
M
SD
104.9 12.8
99.5 12.1
92.5 16.4
11.0
3.3
8.1
3.4
5.9
2.4

F
6.60
20.28

p
.002
<.001

ηp2
.05
.13

HVLT TL

42.2

10.8

36.1

9.8

27.8

6.9

13.18

<.001

.09

HVLT DR
WCST Cat

41.6
3.3

12.8
1.4

36.2
2.7

12.3
1.5

28.8
2.3

10.5
0.8

7.37
5.49

.001
.005

.05
.04

SDMT

0.1

1.0

-0.9

1.2

-1.7

1.0

25.32

<.001

.15

Sig. post hocs*
≤1 vs. ≥3
≤1 vs. 2
≤1 vs. ≥3
≤1 vs. 2
≤1 vs. ≥3
2 vs. ≥3
≤1 vs. ≥3
≤1 vs. 2
≤1 vs. ≥3
≤1 vs. 2
≤1 vs. ≥3
2 vs. ≥3

Note. WRAT-4: Wide Range Achievement Test – reading subtest scaled score (Wilkinson & Robertson, 2006);
VFlu Cat: Verbal Fluency categories scaled score (Delis, Kaplan, & Kramer, 2001); HVLT DR: Hopkins Verbal
Learning Test revised delayed recall T-score (Brandt & Benedict, 2001); HVLT TL: Hopkins Verbal Learning Test
revised total learning T-Score (Brandt & Benedict, 2001); WCST Cat: Wisconsin Card Sorting Test categories
completed (Kongs, Thompson, Iverson, & Heaton, 2000); SDMT: Symbol Digit Modalities Test z-score (Smith.
1973); Conservative cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 7
(Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 1 (King, Sweet,
Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning
System (D-KEFS) Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018);
Grooved Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31
(Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015);
Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015).

EVI Failure and Depression Symptom Endorsement. For these analyses, EXPMAL and
HAD groups were removed. The remaining four groups (controls, NN, ANI, MND) were merged
and divided into six new groups according to their raw PHQ-9 scores. Between subjects
ANOVAs were used to determine whether PHQ-9 symptom ratings influenced EVI failure at
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d
.84
.85
1.77
.59
1.59
.98
1.10
.45
.97
.86
1.83
.78

liberal or conservative cutoffs (Table 15 and 16). PHQ-9 raw scores did not influence EVI failure
(p > .05).

Table 15
Comparison of the total number of Liberal EVIs failed across PHQ-9 Score groups
Total EVIs failed
n
M
SD
F
df
p
None
49
.92
1.1
1.12
5
.351
Minimal
118
.92
1.0
Mild
87
1.3
1.3
Moderate
51
1.1
1.3
Moderately Severe
13
1.2
1.1
Severe
8
1.4
1.3

p2
.017

Note. EVI: Embedded validity indicator; None: PHQ-9 score of 0; Minimal: PHQ-9 score of 1-4; Mild PHQ-9 score
of 5-9; Moderate: PHQ-9 score of 10-14; Moderately Severe: PHQ-9 score of 15-19; Severe: PHQ-9 score greater
than 19 (Kroenke, Spitzer, & Williams, 2001); Liberal cutoffs: Hopkins Verbal Learning Test – Revised recognition
discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain
set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999);
Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4
≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017);
GPB non-dominant hand ≤ 33 (Erdodi, Seke, et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008;
Sugarman & Axelrod, 2015); Animals ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod,
2015).

Table 16
Comparison of the total number of Conservative EVIs failed across PHQ-9 Score groups
Total EVIs failed
n
M
SD
F
df
p
p2
None
49
0.5
0.8
1.415
5
0.22
0.22
Minimal
118
0.4
0.7
Mild
87
0.7
1.1
Moderate
51
0.7
1.1
Moderately Severe
13
0.7
0.8
Severe
8
0.8
1.0
Note. EVI: Embedded validity indicator; None: PHQ-9 score of 0; Minimal: PHQ-9 score of 1-4; Mild PHQ-9 score
of 5-9; Moderate: PHQ-9 score of 10-14; Moderately Severe: PHQ-9 score of 15-19; Severe: PHQ-9 score greater
than 19 (Kroenke, Spitzer, & Williams, 2001); Conservative cutoffs: Hopkins Verbal Learning Test – Revised
recognition discrimination (HVLT-R RD) ≤ 7 (Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to
maintain set (WCST FMS) ≥ 1 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer,
1999); Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS
Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018); Grooved Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al.,
2017); GPB non-dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini,
2008; Sugarman & Axelrod, 2015); Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman &
Axelrod, 2015).
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A Chi-square test of independence was calculated comparing the proportion of
individuals with invalid performance for each of the 6 PHQ-9 raw score groups at six cumulative
cutoffs (Table 17 and 18). No significant interactions were observed between PHQ-9 raw scores
and the level of liberal or conservative EVI failure.

Table 17
Proportion Failing, Risk Ratio, and 2 analysis according to Depressive Symptoms reported at
≥2, ≥3, and ≥4 Liberal EVIs failed
# of EVI
Symptom
%
RR
p
2
2
failures
endorsement
None
22.4
.3
3.79
.580
.11
2
Minimal
23.7
.3
Mild
33.3
.5
Moderate
23.5
.3
Mod. Sev
30.8
.4
Severe
37.5
.6
None
6.1
.1
2.70
.747
.01
3
Minimal
6.8
.1
Mild
11.5
.1
Moderate
9.8
.1
Mod. Sev
15.4
.2
Severe
12.5
.1
None
4.1
<.1
6.61
.252
.02
4
Minimal
1.7
<.1
Mild
8.0
.1
Moderate
5.9
.1
Mod. Sev
0
0
Severe
12.5
.1
Note. EVI: Embedded validity indicator; None: PHQ-9 score of 0; Minimal: PHQ-9 score of 1-4; Mild PHQ-9 score
of 5-9; Moderate: PHQ-9 score of 10-14; Mod. Sev: PHQ-9 score of 15-19; Severe: PHQ-9 score greater than 19
(Kroenke, Spitzer, & Williams, 2001); Liberal cutoffs: Hopkins Verbal Learning Test – Revised recognition
discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain
set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999);
Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4
≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017);
GPB non-dominant hand ≤ 33 (Erdodi, Seke, et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008;
Sugarman & Axelrod, 2015); Animals ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod,
2015).
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Table 18
Proportion Failing, Risk Ratio, and 2 analysis according to Depressive Symptoms reported at
≥1, ≥2, and ≥3 Conservative EVIs failed
# of EVI
Symptom
%
RR
p
2
2
failures
endorsement
None
36.7
.6
6.24
.283
.08
1
Minimal
28.8
.4
Mild
41.4
.7
Moderate
37.3
.6
Mod. Sev
53.8
1.2
Severe
50
1
None
12.2
.1
3.72
.59
.107
2
Minimal
7.6
.1
Mild
16.1
.2
Moderate
11.8
.1
Mod. Sev
15.4
.2
Severe
12.5
.1
None
2.0
>.1
5.90
.316
.02
3
Minimal
2.5
>.1
Mild
6.9
.1
Moderate
7.8
.1
Mod. Sev
0
0
Severe
12.5
.1
Note. None: PHQ-9 score of 0; Minimal: PHQ-9 score of 1-4; Mild PHQ-9 score of 5-9; Moderate: PHQ-9 score of
10-14; Mod. Sev: PHQ-9 score of 15-19; Severe: PHQ-9 score greater than 19 (Kroenke, Spitzer, & Williams,
2001); Conservative cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 7
(Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 1 (King, Sweet,
Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning
System (D-KEFS) Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018);
Grooved Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31
(Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015);
Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015).

Although raw scores provide insight into the frequency of depressive symptoms endorsed
by participants, they are not indicative of symptom severity. Therefore, differences in the total
number of EVIs failed was compared between four levels of symptom severity, as indicated by
participants on Question 10 of the PHQ-9 (Table 19 and Table 20). Participants who endorsed no
symptoms on questions 1-9 were excluded from the analysis. The level of symptom severity did
not influence the number of total number of liberal or conservative EVIs failed.
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Table 19
Comparison of the total number of Liberal EVIs failed across PHQ-9 Distress groups
Total EVIs failed
Level of Distress
n
M
SD
F
df
p
p2
Not Very Difficult
123
1.0
1.2
.744
3
.526
.008
Somewhat Difficult
131
1.0
1.2
Very Difficult
16
1.0
1.3
Extremely Difficult
5
1.8
1.5
Note. Level of distress as indicated by question 10 on the PHQ-9 (Kroenke, Spitzer, & Williams, 2001); Liberal
cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, &
Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, &
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning System (D-KEFS)
Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved
Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 33 (Erdodi, Seke,
et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Animals ≤ 33
(Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015).

Table 20
Comparison of the total number of Conservative EVIs failed across PHQ-9 Distress groups
Total EVIs failed
Level of Distress
n
M
SD
F
df
p
p2
Not Very Difficult
123
.46
.9
1.10
3
.349
.012
Somewhat Difficult
131
.60
.9
Very Difficult
16
.75
1.2
Extremely Difficult
5
1.0
1.3
Note. Level of distress as indicated by question 10 on the PHQ-9 (Kroenke, Spitzer, & Williams, 2001);
Conservative cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 7
(Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 1 (King, Sweet,
Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning
System (D-KEFS) Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018);
Grooved Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31
(Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015);
Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015).
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CHAPTER IV
Discussion
Performance validity testing has been identified as a critical component of
neuropsychological assessment (Board of Directors, 2007; Bush et al., 2005). However, EVI
utility in an HIV+ population is yet to be explored. The objective of the current study was to
begin investigating performance validity within a traditional neuropsychological HAND battery.
To do this, the utility of several EVIs were examined within an undergraduate sample.
Cumulative EVI failure was compared across six groups (e.g. controls, EXPMAL, NN, ANI,
MND, and HAD). The relationship between EVI failure and neurocognitive performance as well
as self-reported depression was explored.
Within the present HAND battery, eight EVIs were identified that demonstrated
acceptable signal detection profiles (AUC  .70) within the student sample. Consistent with our
a priori hypothesis, the number of EVIs failed differed across the six groups, and was predictive
of neuropsychological test scores within the HIV+ sample. Interestingly, and contrary to
expectations, depression as measured by the PHQ-9 was independent of EVI failure.
Determining EVI cutoffs using the student sample
The signal detection profiles of eight EVIs were explored prior to their application to the
HIV+ sample. All individual EVIs were significant predictors of the criterion variable
(experimental malingering or Pass/Fail status on the WCT),and produced a classification
accuracy hovering around the Larrabee limit: .50 sensitivity at .90 specificity (Erdodi et al.,
2014). Failure of a single EVI is insufficient evidence of invalid performance (Boone, 2013;
Rickards, Cranston, Touradji, & Bechtold, 2017). Therefore, participants were classified based
on their cumulative EVI failures as valid (2 failures at liberal cutoffs; 1 failures at
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conservative cutoffs), borderline (3 failures at liberal cutoffs; 2 failures at conservative cutoffs),
or invalid (4 failures at liberal cutoffs; 3 failures at conservative cutoffs). The “indeterminate
range” (i.e., borderline) has been recently introduced as a third category in the traditional binary
classification system to formally acknowledge the inherent uncertainty in the performance
validity assessment (Erdodi, 2017).
The present study supports the dual criterion model of EVI calibration, which suggests
that multiple criterion PVTs should be used when calibrating an EVI to monitor potential
instrumentation artifacts (Erdodi, Hurtubise, et al., 2018). Previous research suggested that the
sensory modality and cognitive domain of a criterion PVT may inflate the sensitivity and
specificity profile of an EVI with congruent features. Conversely, incongruence may lead to
underestimating the classification accuracy (Erdodi, 2017; Erdodi & Roth, 2017).
Indeed, the effect of domain specificity was observed in the current study. For example,
the WCT appears to be a measure of word list learning and memory and has been validated as a
free-standing PVT (Barhon, Batchelor, Meares, Chekaluk, & Shores, 2015; Davis, 2014; Erdodi,
Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014; Erdodi et al., 2017; Pearson, 2009). Within
the present study, the WCT had a strong relationship with HVLT-R, a measure of auditory verbal
learning, memory, and recognition, and weaker relationships with D-KEFS Trails, a measure of
visuomotor processing speed and cognitive flexibility. It is worth noting that a strong
relationship was observed between the WCT and GPB-ND (a test of manual dexterity), which
suggests that the domain/modality specificity effect may be more complex than initially
proposed, or that the WCT is a robust instrument that provides an unbiased index of performance
validity within the HAND battery.
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The experimental malingering paradigm was used as an alternative criterion variable, as
it theoretically circumvents this limitation by allowing examinees to decide on which tests they
choose to “demonstrate impairment”. At the same time, the most notable weakness of
experimental malingering as a criterion is the absence of any real external incentive to perform
poorly while avoiding detection. As such, studies relying on this design have been criticized for
inflating the classification accuracy of predictor PVTs by creating diagnostically pure groups
with minimal overlap but little etiological validity. In this case, the signal detection model is
applied to a measurement context that is unrealistically easy to characterize, thereby reducing its
ecological validity. Indeed, cutoffs developed using the experimental malingering paradigm
often fail to replicate (Rogers, 2008).
Similarly, experimental malingering comes with unique threats to internal validity.
Namely, researchers rely exclusively on participants’ ability and willingness to adhere to
instructions. In reality, participants assigned to the control group often fail PVTs (An et al.,
2012; 2017; 2018), contaminating the valid group. Conversely, participants assigned to the
experimental malingering group may not make a genuine effort to produce credible impairment.
Indeed, large variability in participants’ execution of instructions was observed within the
present study: the total number of EVI failures ranged from 0 to 8 regardless of whether liberal
or conservative cutoffs were used. In other words, some made little-to-no attempt to appear
impaired, while others excessively exaggerated deficits.
In contrast, using the WCT provides an opportunity to operationalize valid versus invalid
responding using a well-established instrument. Psychometric definitions of non-credible
responding have the advantage of refraining from making specific (and often untestable)
assumptions about the validity of a given neurocognitive profile. It also allows researchers to
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correct for the shortcomings of the experimental malingering design, by psychometrically
defining valid and invalid. Thus, it correctly reclassifies examinees who were supposed to
malinger but didn’t and those who were supposed to perform at true ability but didn’t as valid
and invalid, respectively.
Hypothesis 1: EVI failure will vary according to group membership (EXPMAL= HAD >
MND = ANI > NN = CON).
As hypothesized, between-group differences in cumulative EVI failure were observed.
Controls and NN individuals had the fewest number of EVI failures, supporting the notion that
EVI failure is insensitive to variations in education, age, and gender (An et al., 2012). On
average, both controls and NN had cumulative EVI profiles that were classified as valid. HAD
and EXPMAL groups failed the largest number of EVIs and produced invalid profiles at both
liberal and conservative cutoffs. As mentioned, certain clinical populations, such as dementia,
are exempt from PVTs due to genuine and severe neurological impairments that provide a more
clinically accurate interpretation for a high number of PVT failures (Boone, 2013; Merten,
Bossink, & Schmand, 2007).
Although individuals diagnosed with ANI had a greater number of EVI failures than
controls, they produced valid profiles, supporting the use of EVIs in HAND, as the validity
cutoffs do not misclassify individuals with genuine mild cognitive deficits as non-credible.
Individuals with MND had a greater number of EVI failures than those with ANI, and on
average, produced valid profiles when liberal cutoffs were applied but borderline profiles when
applying conservative cutoffs. These findings suggest that individuals with MND can be
effectively protected against being misclassified as non-credible using more liberal multivariate
cutoffs, but they are vulnerable to false positive errors if conservative cutoffs are applied.
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Nevertheless, the elevated mean number of EVI failures in this group suggests that the
neurocognitive profiles of individuals with MND are at a higher risk for being misclassified as
invalid. Therefore, the issue of false positives in this population warrants further investigation.
Differentiating invalid responding from genuine impairment is beyond the scope of the
present study. However, a strong linear relationship between the severity of cognitive
impairment and EVI failure was observed within the HIV+ sample (HAD > MND > ANI > NN;
Antinori et al., 2007). Although the true nature and clinical interpretation of this dose-response
relationship remains unclear, there are three potential explanations.
First, as EVIs are contained within ability tests, they are more prone to false positives in
individuals with genuine cognitive impairments (Boone, 2013; DeRight & Carone, 2015).
Therefore, the increasing number of EVI failures with HAND severity may reflect an elevated
rate of false positives. Alternatively, the criteria used to determine an individual’s HAND
diagnosis may have been contaminated by non-credible responding, such that invalid
performance resulted in the misclassification of an individual’s cognitive profile as impaired.
Lastly, rather than due to cognitive performance, the relationship between HAND severity and
EVI failure may result from a secondary variable (e.g. pain, fatigue, depression, complex trauma
history) that is commonly comorbid with HAND severity and accompanies increased risk of EVI
failure (Bigler, 2014).
Hypothesis 2: Those failing a greater number of EVIs will perform more poorly on
neuropsychological tests.
A persistent concern in performance validity assessment is that elevated BR Fail is a
consequence of false positives in neurocognitively impaired individuals (Bigler, 2014). To
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investigate this idea, only individuals diagnosed as NN, ANI, and MND were included within the
analysis.
Overall, individuals with valid profiles outperformed those with invalid profiles on six
measures of cognitive ability. The cognitive profiles of the borderline cases tended to present
more similarly to invalid, rather than valid, profiles, as reported previously (Erdodi, 2017).
Taken together, the findings suggest that an inverse relationship exists between neurocognitive
performance and EVI failure, replicating previous studies in undergraduates (An, Zakzanis, and
Joordens, 2012; DeRight and Jorgensen, 2015), mixed clinical samples (Erdodi, Abeare, et al.,
2017), and non-litigating epilepsy surgery candidates (Loring, Lee, & Meador, 2004).
EVIs are contained within neuropsychological tests. Therefore, collinearity (i.e., shared
error variance) cannot be fully eliminated, as the same test is used to measure both cognitive
ability and performance validity. Within the present study, all variables that were used as validity
indicators were excluded from this analysis. The limited number of tests within the HAND
battery required some cognitive measures to be derived from other variables within a given test
(e.g. verbal fluency categories, HVLT-R total learning, HVLT-R delayed recall, and WCST
categories). Within these cognitive measures, the relationship between cognitive ability and EVI
failure may also be influenced by collinearity. However, the WRAT-4 reading subtest and
SDMT did not contain any EVIs. Although it is impossible to completely separate different
cognitive domains, the WRAT-4 reading subtest emphasizes a domain (e.g. reading) not
contained within the other neuropsychological tests within the battery. Valid profiles
outperformed borderline and invalid profiles on the WRAT-4 and SDMT, suggesting that
individuals who fail a greater number of EVIs are more likely to have impaired scores in general,
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rather than in a domain, modality, or test-specific manner, reinforcing the global deleterious
effect of non-credible responding (Boone, 2013; Larrabee, 2012).
Hypothesis 3: Regardless of HIV status, individuals who have elevated PHQ-9 scores will
fail more EVIs than those who do not.
An alternate explanation for Hypothesis 1 is that a third variable, such as depression, may
account for between-group differences in EVI failure. It was hypothesized that individuals
reporting more symptoms of depression would fail a greater number of EVIs. This prediction
was not supported by the data: no relationship was observed between PHQ-9 scores and EVI
failure. Further, in those reporting elevated levels of depression, symptom severity was
independent of total EVI failures.
Previous research suggested BRFail is related to emotional distress, somatic concerns,
fatigue, pain, sensory disturbances, and limited English proficiency (Erdodi, Seke et al., 2017;
Erdodi, Nussbaum, et al., 2017; Erdodi et al., 2016; Greher & Wodushek, 2017, Whiteside et al.,
2010). Further, PVT failure has been linked to depression defined by a score of 19 on the Beck
Depression Inventory-II (BDI-II; McCormick, Yoash-Gantz, McDonald, Campbell, & Tupler,
2013). However, similar to our study, An, Zakzanis, and Joordens (2012) found no difference
between valid and invalid profiles on the BDI in a student sample. The inconsistent relationship
between self-reported depression and PVT failure may reflect methodological differences.
Clinical depression is often comorbid with neurological problems (Christopher & MacDonald,
2010), and can even manifest as cognitive deficits in individuals without neurological disorders.
Indeed, certain defining features of depression (psychomotor retardation, low energy, diminished
ability to think and concentrate, indecisiveness; American Psychiatric Association, 2013) can
manifest as impairment on neuropsychological testing (i.e., low visuomotor speed and slow
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simple reaction time, attention, working memory). Therefore, when comparing PVT failures
between those with probable depression and those without as done by McCormick and
colleagues (2013), genuine cognitive impairments may inflate BRFail. In contrast, the present
study and that conducted by An and colleagues (2012) investigated PVT failure across a
continuum of depressive symptoms and may not have captured clinical impairments related to
depression.
Limitations
Several limitations within the present study reduce the generalizability of its findings.
The most notable is the use of an HIV- undergraduate sample to determine the signal detection
profile and cutoff scores of EVIs in an HIV+ population. In contrast to the HIV+ sample,
undergraduates were younger, more educated, and comprised of a greater proportion of females.
Although theoretically resistant to their influences, the demographic variables of the student
sample may have produced inappropriately liberal cutoffs when applied to the HIV+ sample.
However, as neurocognitive tests and EVI cutoffs primarily utilize scales that correct for age,
education, and gender it is unlikely that such factors (e.g. cognitive reserve) would influence the
findings of the present study. An additional demographic variable not taken into consideration is
limited English proficiency. As English proficiency increases the risk of EVI failure,
undergraduate and HIV+ group differences may reduce the translatability of the EVIs (Erdodi,
Nussbaum, et al., 2017). A related limitation is the lack of free-standing PVTs included within
the HAND battery. Free-standing PVTs are designed to estimate response credibility and are
much less sensitive to genuine impairment than EVIs (Greher & Wodushek, 2017). Their
inclusion within the HAND battery would provide several PVT criteria to determine sensitivity
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and specificity of EVI cutoffs within the HIV+ sample. Further, free-standing PVTs would
provide EVI-independent insight into the credibility of a response set on a case-by-case basis.
A general limitation to HAND research is the way HAND status is assigned. Functional
impairments are determined via self-report measures. These measures ultimately distinguish
between ANI and MND groups (Antinori et al., 2007). Without an objective measure of
functional changes, patient descriptions of subjective experiences may create artificial group
differences.
Future Directions
The present study addressed limitations of previous PVT research using a single-blind
paradigm in the undergraduate sample (An, Zakzanis, & Joordens, 2012) and relying on multiple
criterion PVT. However, the current study is not without limitation. The data collected from the
HIV+ population were archival and included no criterion PVT. Therefore, the signal detection
analyses for EVIs within the HAND battery could not be extended to the HIV+ population.
Future studies investigating cognitive functioning within the HAND population should include
free-standing PVTs to allow researchers to address the collinearity issue (i.e., the confluence of
genuine impairment and non-credible responding) and improve the internal validity of signal
detection analyses.
The relationship between neurocognitive performance and EVI failure was confounded
by collinearity in all but two tests. By including several independent tests encompassing a variety
of cognitive domains, future studies could explore whether EVI failure and cognitive
impairments occur in a domain-specific or random pattern. If the EVIs failed are restricted to
tests assessing performance within a single cognitive domain, then it is likely that non-credible
profiles are a consequence of inflated false positive rates. Thus, future research in this area
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would be supported by validating EVIs using HIV+ samples and increasing the number of
neurocognitive tests included within the battery. In the meantime, for clinical purposes, at least
two free-standing PVTs should be routinely administered in addition to the standard HAND
battery, consistent with the recommendations of professional organizations (Bush et al., 2005;
Heilbronner et al., 2009).
Summary and Conclusions
The present study is the first to demonstrate that BRFail varies on EVIs within the HAND
battery as a function of classification severity in an HIV+ population. These results may reflect
elevated false positives due to genuine cognitive impairment or due to a third unmeasured
variable. Worth mentioning, although the number of EVIs failed differed between groups, the
average individual from NN and ANI groups was classified as having a valid profile. Although
EVIs have been validated as a means to determine non-credible responding in several clinical
populations, they are considered inappropriate in others (i.e. intellectual disability and dementia;
Davis, 2018; Shandera et al., 2010). Thus, HAD populations should be excempt from
performance validity testing. It is too early to determine whether MND due to HIV+ should be
added to the list of exempt categories, but it warrants further empirical research.
Even in populations where EVI use is recommended, other factors besides invalid
performance have been identified as contributing to EVI failure including alterations in white
matter integrity (Clark et al., 2016), pain, and sleep (Johnson-Greene, Brooks, & Ference, 2013).
All three of these factors are prevalent in HIV+ populations and may contribute to increased risk
of EVI failure. The present study suggests that it is unlikely that the factor underlying increased
EVI failure is depression.
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In contrast, the relationship between EVI failure and HAND diagnosis may be due to
invalid performance resulting in lower cognitive test scores and a more severe clinical diagnosis.
Over a one year period, cognitive impairment levels fluctuate in almost half of individuals
diagnosed with HAND (Antinori et al., 2007). If invalid responding is the true cause of low
scores (rather than genuine impairment), it could provide an explanation for these fluctuations in
the cognitive profile. The general relationship between cognitive impairment and EVI failure
may support this hypothesis but further research is required, given the clinical implications of the
conclusion (fluctuations of test taking effort vs. cognitive ability).
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APPENDIX A: INTAKE QUESTIONNAIRE
Gender: Female

Male

Other

Age: _________________
Handedness: Right

Left

Ambidextrous

(i.e., able to use both hands with equal ease)

Years of Education: _________
1. Have you ever been diagnosed with one of the following?
a) Neurological disorder (e.g. stroke, multiple sclerosis)?
Yes

No

b) Have you ever had a traumatic brain injury or concussion?
Yes

No

2. Are you currently experiencing severe anxiety, depression, manic symptoms?
Yes

No

3. Do you have a history of trauma?
Yes

No

If yes, physical

emotional

sexual

prefer not to say
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APPENDIX B.1: INSTRUCTIONS FOR SIMULATED MALINGERING GROUP
Imagine that you were in a car accident in which another driver hit your car. You were
knocked unconscious, and woke up in the hospital. The doctors told you that you had some
bleeding in your brain after the accident.
Because the other driver is at fault, you have decided to take legal action against the
driver. Your lawyer said that you may get more money if you look like you have sustained
significant injuries because of the accident. You have decided to fake or exaggerate symptoms of
a brain injury in order to increase the settlement you will receive. You have been told that
common symptoms after a brain injury include difficulties with memory, concentrating, and
being slower in responding.
The other driver’s lawyer requires you to complete cognitive testing to determine if you
sustained significant symptoms because the car accident. You know you can win a better
settlement if you can convince the examiner that you have experienced significant brain damage.
But if the examiner detects that you are faking, you are likely to lose the lawsuit.
You are about to take a series of cognitive tests that would be used in such a situation. I
would like you to pretend you have brain damage, but in a believable way, such that your
examiner cannot tell that you are attempting to fake a brain injury.
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APPENDIX B.2: INSTRUCTIONS FOR NON-MALINGERING GROUP
You are about to take a series of cognitive tests. Some of the tests are easy and some are
hard. I would like you to try your best on all of the tests.
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APPENDIX C.1: POST-SESSION QUESTIONNAIRE FOR NON-MALINGERING
CONTROL CONDITION
Discuss briefly what you were asked to do in this study:

How much did you try to follow the instructions during testing?
0 ---------1---------2---------3---------4---------5---------6---------7---------8---------9---------10
Did not try at all

Tried my
absolute best
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APPENDIX C.2 POST-SESSION QUESTIONNAIRE FOR SIMULATED MALINGERING
CONDITION
Discuss briefly what you were asked to do in this study:

How much did you try to follow the instructions during testing?
0 ---------1---------2---------3---------4---------5---------6---------7---------8---------9---------10
Did not try at all

Tried my
absolute best

How much could you imagine or relate to the motor vehicle accident scenario described?
0 ---------1---------2---------3---------4---------5---------6---------7---------8---------9---------10
Not at all

I could imagine
it very vividly

What did you do during testing to pretend that you had cognitive difficulties? (circle as many as
applies)
A.
B.
C.
D.
E.
F.
G.

I responded to questions and completed tasks slower than usual
I answered questions incorrectly even though I knew the answer
I acted confused on how to complete the task
I asked the examiner to repeat questions
I didn’t follow the test instructions
I didn’t pretend
Other: ____________________________________________
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